WARNING:enrichment.sec_edgar_client:Using default User-Agent. Please set your email!
INFO:__main__:================================================================================
INFO:__main__:EXHAUSTIVE ENRICHMENT STARTED
INFO:__main__:================================================================================
INFO:__main__:Total companies: 2491
INFO:__main__:Start time: 2025-11-16 05:14:39
INFO:__main__:Getting initial classification statistics...
INFO:__main__:================================================================================
INFO:__main__:STARTING CLINICALTRIALS ENRICHMENT
INFO:__main__:================================================================================
INFO:__main__:Processing 2483 companies through ClinicalTrials.gov API
INFO:enrichment.clinicaltrials_client:Processing 2483 companies for clinical trials enrichment
INFO:enrichment.clinicaltrials_client:NO TRIALS: 10X Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: 1Cell.Ai
INFO:enrichment.clinicaltrials_client:NO TRIALS: 1cBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: 64x Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: 92Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: AAT Bioquest
INFO:enrichment.clinicaltrials_client:NO TRIALS: ACI Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: ACON Laboratories
INFO:enrichment.clinicaltrials_client:CLINICAL: ACS Diagnostics -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ACT Biotech Inc -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 10/2483 (0.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: ADARx Pharmaceuticals -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ADAXION Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: ADRx
INFO:enrichment.clinicaltrials_client:NO TRIALS: ADS Biosystems
INFO:enrichment.clinicaltrials_client:CLINICAL: AEON Biopharma -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AG Scientific
INFO:enrichment.clinicaltrials_client:CLINICAL: AIVITA Biomedical -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AKSO Biopharmaceutical
INFO:enrichment.clinicaltrials_client:NO TRIALS: ALLInBio
INFO:enrichment.clinicaltrials_client:CLINICAL: ALX Oncology -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 20/2483 (0.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ALZpath
INFO:enrichment.clinicaltrials_client:NO TRIALS: AM Chemicals
INFO:enrichment.clinicaltrials_client:CLINICAL: AMAG Pharmaceuticals -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: AN2 Therapeutics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: APstem Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: ARIZ Precision Medicine -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ARNA Genomics -> 2 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: ARS Pharmaceuticals -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ATUM
INFO:enrichment.clinicaltrials_client:CLINICAL: AVITA Medical -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 30/2483 (1.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aanastra
INFO:enrichment.clinicaltrials_client:CLINICAL: Aardvark Therapeutics -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aarvik Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aayam Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ab Studio
INFO:enrichment.clinicaltrials_client:NO TRIALS: AbTherx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abalone Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: AbbVie -> 15 trials, Public/Late-Stage
ERROR:enrichment.clinicaltrials_client:Failed to search trials for Abbiotec: ('Connection aborted.', RemoteDisconnected('Remote end closed connection without response'))
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abbiotec
INFO:enrichment.clinicaltrials_client:NO TRIALS: AbboMax
INFO:enrichment.clinicaltrials_client:Progress: 40/2483 (1.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Abbott -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abcam
INFO:enrichment.clinicaltrials_client:CLINICAL: Abcentra -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abcepta
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abeomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abilita Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abiocode
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abiosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ablexis
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abram Scientific
INFO:enrichment.clinicaltrials_client:Progress: 50/2483 (2.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Abterra Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Acadia Pharmaceuticals -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Accelagen -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Accelero Biostructures
INFO:enrichment.clinicaltrials_client:CLINICAL: Acceleron Pharma -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AccendoWave
INFO:enrichment.clinicaltrials_client:NO TRIALS: AccuDava
INFO:enrichment.clinicaltrials_client:NO TRIALS: AccuraGen
INFO:enrichment.clinicaltrials_client:CLINICAL: Accuray -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Accurus Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 60/2483 (2.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Accuryn Medical -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: AceLink Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AcelaBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acelot
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acepix Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Acepodia -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Achelois BioPharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: Achira
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acme Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Acorda Therapeutics -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 70/2483 (2.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acrigen Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acro Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acrobat Genomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Actio Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Active Motif
INFO:enrichment.clinicaltrials_client:CLINICAL: Actym Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Acura Pharmaceuticals -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AcuraStem
INFO:enrichment.clinicaltrials_client:NO TRIALS: Acurex Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Acutus Medical -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 80/2483 (3.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Adagio Medical -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Adanate -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Adaptyx Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Adari Cell Science
INFO:enrichment.clinicaltrials_client:CLINICAL: Adcentrx Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AddexBio
INFO:enrichment.clinicaltrials_client:CLINICAL: Addition Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Adicet Bio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Adona Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: AdvanBio
INFO:enrichment.clinicaltrials_client:Progress: 90/2483 (3.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Bifurcation Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Biomatrix
INFO:enrichment.clinicaltrials_client:CLINICAL: Advanced Bionics -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Advanced Brain Monitoring -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Cell Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Microbubbles
INFO:enrichment.clinicaltrials_client:CLINICAL: Advanced NanoTherapies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Advanced Orthopaedic Solutions -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Process Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Protein Production
INFO:enrichment.clinicaltrials_client:Progress: 100/2483 (4.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Sterilization Products
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advanced Targeting Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Advansta
INFO:enrichment.clinicaltrials_client:CLINICAL: Advenchen Laboratories -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Adventris Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Adverum Biotechnologies -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aelan Cell Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Aeovian Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aequita Bioworks
INFO:enrichment.clinicaltrials_client:CLINICAL: Aerie Pharmaceuticals -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 110/2483 (4.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Aerin Medical -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: AeroRx Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aether Biomachines
INFO:enrichment.clinicaltrials_client:CLINICAL: Aethlon Medical -> 3 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: AfaSci -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Afecta Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Affinity Biosensors
INFO:enrichment.clinicaltrials_client:NO TRIALS: Agastiya Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Agena Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Agendia -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 120/2483 (4.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: AgileBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Agilent
INFO:enrichment.clinicaltrials_client:CLINICAL: Agios Pharmaceuticals -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: AiViva BioPharma -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aikium
INFO:enrichment.clinicaltrials_client:NO TRIALS: AimPlex Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ainnocence
INFO:enrichment.clinicaltrials_client:CLINICAL: Ainos -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aivo Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: AivoCode
INFO:enrichment.clinicaltrials_client:Progress: 130/2483 (5.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aizen Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aizon
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ajinomoto Bio-Pharma Services
INFO:enrichment.clinicaltrials_client:CLINICAL: Akero Therapeutics -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AkrivisBio
INFO:enrichment.clinicaltrials_client:CLINICAL: Akura Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aladdin Scientific
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alamar Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Alcon -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Alector -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 140/2483 (5.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Alessa Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alexander Shulgin Research Institute
INFO:enrichment.clinicaltrials_client:CLINICAL: Alexion Pharmaceuticals -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alfa Scientific Designs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Algen Biotechnologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alida Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Alife -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aligos Therapeutics -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Alimentiv -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Alimera Sciences -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 150/2483 (6.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: AlivaMab Biologics
INFO:enrichment.clinicaltrials_client:CLINICAL: AliveCor -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AliveGen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alixia
INFO:enrichment.clinicaltrials_client:CLINICAL: Alkahest -> 12 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AllCells
INFO:enrichment.clinicaltrials_client:CLINICAL: Allay Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Allegro Ophthalmics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Allele Biotechnology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Allelica
INFO:enrichment.clinicaltrials_client:Progress: 160/2483 (6.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Allez Health
INFO:enrichment.clinicaltrials_client:CLINICAL: Allogene Therapeutics -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Allucent
INFO:enrichment.clinicaltrials_client:NO TRIALS: Allvivo Vascular
INFO:enrichment.clinicaltrials_client:CLINICAL: Alnylam Pharmaceuticals -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Alpha Medical Instruments -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alphalyse
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alstem
INFO:enrichment.clinicaltrials_client:CLINICAL: Alta Biomed -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Altagenics
INFO:enrichment.clinicaltrials_client:Progress: 170/2483 (6.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Altasciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Altaviz
INFO:enrichment.clinicaltrials_client:CLINICAL: Altay Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AlterG
INFO:enrichment.clinicaltrials_client:CLINICAL: Alterome Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AltiBio
INFO:enrichment.clinicaltrials_client:CLINICAL: Alto Neuroscience -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Altos Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: AltruBio -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Altus Life Science
INFO:enrichment.clinicaltrials_client:Progress: 180/2483 (7.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aluda Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Alume Biosciences -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Alumis -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aluna
INFO:enrichment.clinicaltrials_client:NO TRIALS: Alveo Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Alzheon -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: AmMax Bio -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Amador Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amaros
INFO:enrichment.clinicaltrials_client:CLINICAL: Amber Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 190/2483 (7.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amber Ophthalmics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amberstone Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Ambrx -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ambry Genetics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ameridose
INFO:enrichment.clinicaltrials_client:CLINICAL: Amgen -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Amneal Pharmaceuticals -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Amphastar Pharmaceuticals -> 20 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AmplifiDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amplifica
INFO:enrichment.clinicaltrials_client:Progress: 200/2483 (8.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amplify Surgical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amplo Biotechnology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amprion
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amrex Electrotherapy
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amsino
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amuza
INFO:enrichment.clinicaltrials_client:NO TRIALS: Amydis Diagnostics
INFO:enrichment.clinicaltrials_client:CLINICAL: Amygdala Neurosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: AnaBios
INFO:enrichment.clinicaltrials_client:NO TRIALS: AnaSpec
INFO:enrichment.clinicaltrials_client:Progress: 210/2483 (8.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ananya Health
INFO:enrichment.clinicaltrials_client:CLINICAL: AnaptysBio -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Anchor Molecular
INFO:enrichment.clinicaltrials_client:CLINICAL: AnchorDx -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ancora Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ancora Heart -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Andromeda Surgical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aneuvo -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Angarus Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Angeles Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 220/2483 (8.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: AngioSafe -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Angiocrine Bioscience -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Angitia Biopharmaceuticals -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Anixa Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Ankasa Regenerative Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Annexon Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ansa Biotechnologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Ansun BioPharma -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Antares Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Antharis Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 230/2483 (9.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Antheia
INFO:enrichment.clinicaltrials_client:CLINICAL: Anthera Pharmaceuticals -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Antibodies Incorporated -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Antibody Design Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Antibody Solutions
INFO:enrichment.clinicaltrials_client:NO TRIALS: Antigen Discovery
INFO:enrichment.clinicaltrials_client:CLINICAL: Antiva Biosciences -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Anviron
INFO:enrichment.clinicaltrials_client:CLINICAL: Anwita Biosciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Apellis Pharmaceuticals -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 240/2483 (9.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Apertor Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Apeximmune
INFO:enrichment.clinicaltrials_client:NO TRIALS: Apollo Biologics
INFO:enrichment.clinicaltrials_client:CLINICAL: Apollomics -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Apostle Inc
INFO:enrichment.clinicaltrials_client:NO TRIALS: Applied BioCode
INFO:enrichment.clinicaltrials_client:NO TRIALS: Applied Biomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Applied Cells
INFO:enrichment.clinicaltrials_client:CLINICAL: Applied Cognition -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Applied Medical
INFO:enrichment.clinicaltrials_client:Progress: 250/2483 (10.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Applied Spectral Imaging -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Applied StemCell
INFO:enrichment.clinicaltrials_client:NO TRIALS: Applied Viromics
INFO:enrichment.clinicaltrials_client:CLINICAL: Apreo Health -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Apricus Biosciences -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Apros Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aptah Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Aptitude Medical Systems -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aptose Biosciences -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aqtual -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 260/2483 (10.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Aqua Medical -> 11 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aquedeon Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aqur Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aracari Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aragen Life Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aralez Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Arbor Vita
INFO:enrichment.clinicaltrials_client:CLINICAL: Arcturus Therapeutics -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arcus Biosciences -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arcutis Biotherapeutics -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 270/2483 (10.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Arda Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ardelyx -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arena Pharmaceuticals -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Argonaut Manufacturing Services
INFO:enrichment.clinicaltrials_client:CLINICAL: ArgÃ¡ Medtech -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arialys Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aridis Pharmaceuticals -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Arima Genomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Arisan Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ark Clinical Research
INFO:enrichment.clinicaltrials_client:Progress: 280/2483 (11.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ark Diagnostics
INFO:enrichment.clinicaltrials_client:CLINICAL: Armata Pharmaceuticals -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Armonica Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Arnatar Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Array BioPharma -> 11 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Arriello
INFO:enrichment.clinicaltrials_client:CLINICAL: Arrowhead Pharmaceuticals -> 20 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arsenal Biosciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Artelo Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Artera
INFO:enrichment.clinicaltrials_client:Progress: 290/2483 (11.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Artery Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arthrex -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Arthrosi Therapeutics -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Artificial -> 3 trials, Clinical Stage
ERROR:enrichment.clinicaltrials_client:Failed to search trials for Artis BioSolutions Inc: ('Connection aborted.', RemoteDisconnected('Remote end closed connection without response'))
INFO:enrichment.clinicaltrials_client:NO TRIALS: Artis BioSolutions
INFO:enrichment.clinicaltrials_client:CLINICAL: Artiva Biotherapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Arytha Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Ascendis Pharma -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: AscentX Medical -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Asegua Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 300/2483 (12.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Asha Pharma -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Asher Biotherapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ashvattha Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Asieris Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Askgene Pharma -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aspa Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aspen Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aspen Medical products -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Aspen Neuroscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Assay Biotechnology -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 310/2483 (12.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Assembly Biosciences -> 20 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Assertio Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Astoriom
INFO:enrichment.clinicaltrials_client:CLINICAL: AstraZeneca -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Astraea Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: AtaCor Medical -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Atara Biotherapeutics -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Atec Spine -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Atengen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Athelas
INFO:enrichment.clinicaltrials_client:Progress: 320/2483 (12.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Athos Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Atia Vision -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Atila Biosystems
INFO:enrichment.clinicaltrials_client:CLINICAL: Atmo Biosciences -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Atomic AI
INFO:enrichment.clinicaltrials_client:NO TRIALS: Atonarp
INFO:enrichment.clinicaltrials_client:NO TRIALS: Atraverse Medical
INFO:enrichment.clinicaltrials_client:CLINICAL: AtriCure -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Atropos Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Attovia Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 330/2483 (13.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Attune Neurosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aubex Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Auctus Surgical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Augmenta Bioworks
INFO:enrichment.clinicaltrials_client:CLINICAL: Aulos Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Auransa
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aureka Biotechnologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Aurora Biolabs -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aurora Microplates
INFO:enrichment.clinicaltrials_client:CLINICAL: Aurora Spine -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 340/2483 (13.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: AusperBio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Austral Biologicals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Autobahn Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Autonomous Medical Devices -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avacen Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avails Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: AvantGen
INFO:enrichment.clinicaltrials_client:CLINICAL: Avantec Vascular -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Avax Technologies -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avella Specialty Pharmacy
INFO:enrichment.clinicaltrials_client:Progress: 350/2483 (14.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avellino Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avenda Health
INFO:enrichment.clinicaltrials_client:CLINICAL: Avenue Biosciences -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Avenzo Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avenzoar Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Averto Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avesta76 Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Avidity Biosciences -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Avinger -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Avirmax -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 360/2483 (14.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Avisi Technologies -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Aviva Systems Biology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Avive Solutions
INFO:enrichment.clinicaltrials_client:CLINICAL: Avvio Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Axbio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Axim Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Axiom
INFO:enrichment.clinicaltrials_client:NO TRIALS: AxisPharm
INFO:enrichment.clinicaltrials_client:CLINICAL: Axon Therapies -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Axonics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 370/2483 (14.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Axxin
INFO:enrichment.clinicaltrials_client:CLINICAL: Azalea Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Azena Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Azenta Life Sciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Azora Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BALT -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BCN Biosciences -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BP Logix Life Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: BPS Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: BTB Therapeutics -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 380/2483 (15.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: BacStitch DNA
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bachem
INFO:enrichment.clinicaltrials_client:NO TRIALS: Balto Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bash Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Basilard BioTech
INFO:enrichment.clinicaltrials_client:CLINICAL: Bausch Health -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Baxter International
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bayer BioPartnering Solutions
INFO:enrichment.clinicaltrials_client:CLINICAL: Baylx -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bayside Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 390/2483 (15.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: BeOne Medicines -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Beam Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Beckman Coulter Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Becton Dickinson -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Behavioral Pharma -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Bel Air Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Belharra Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Belite Bio -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Beloteca
INFO:enrichment.clinicaltrials_client:NO TRIALS: Benchling
INFO:enrichment.clinicaltrials_client:Progress: 400/2483 (16.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Benitec Biopharma -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Benthic Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bespoke Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Beta Bionics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bexson Biomedical
INFO:enrichment.clinicaltrials_client:CLINICAL: Big Eye Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BigHat Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: BillionToOne
INFO:enrichment.clinicaltrials_client:CLINICAL: Binacea Pharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bio Applied Technologies Joint
INFO:enrichment.clinicaltrials_client:Progress: 410/2483 (16.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Bio-Rad -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bio4t2
INFO:enrichment.clinicaltrials_client:CLINICAL: BioAge Labs -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioAmp Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioAssay Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: BioAtla -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BioCardia -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BioChain -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BioCorRx -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BioCryst Pharmaceuticals -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 420/2483 (16.9%)
ERROR:enrichment.clinicaltrials_client:Failed to search trials for BioDot Inc: ('Connection aborted.', RemoteDisconnected('Remote end closed connection without response'))
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioDot
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioDuro
INFO:enrichment.clinicaltrials_client:CLINICAL: BioEclipse Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioGenex
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioGrammatics
INFO:enrichment.clinicaltrials_client:CLINICAL: BioJiva -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioLegacy Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioLegend
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioMap
INFO:enrichment.clinicaltrials_client:CLINICAL: BioMarin Pharmaceutical -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 430/2483 (17.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: BioNTech -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioPioneer
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioProduction Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: BioQ Pharma -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioSapien
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioSciencesCorp
INFO:enrichment.clinicaltrials_client:CLINICAL: BioSpring -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioSpyder Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioSuperior
INFO:enrichment.clinicaltrials_client:CLINICAL: BioSyn -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 440/2483 (17.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioTechLogic
INFO:enrichment.clinicaltrials_client:CLINICAL: BioTheryX -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioTuring
INFO:enrichment.clinicaltrials_client:NO TRIALS: BioVinc
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bioagilytix
INFO:enrichment.clinicaltrials_client:CLINICAL: Biocare Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biocheck
INFO:enrichment.clinicaltrials_client:CLINICAL: Biogen -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Biolase -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biolinq
INFO:enrichment.clinicaltrials_client:Progress: 450/2483 (18.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biolog
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biologic Input Output Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: Biomarker Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Biomea Fusion -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Biomed -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Biomerica -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biomiga
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biomonadic
INFO:enrichment.clinicaltrials_client:CLINICAL: Bionano Genomics -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bionaut Labs
INFO:enrichment.clinicaltrials_client:Progress: 460/2483 (18.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bioneer
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bionexus
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bionova Scientific
INFO:enrichment.clinicaltrials_client:CLINICAL: Biopartners -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biopeptide Co.
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biopico Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bioprocess AI
INFO:enrichment.clinicaltrials_client:CLINICAL: Biora Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BiosPacific
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biosero
INFO:enrichment.clinicaltrials_client:Progress: 470/2483 (18.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Biosplice Therapeutics -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biotechnology industry in Boston
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biotium
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biotricity
INFO:enrichment.clinicaltrials_client:CLINICAL: Biovest -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Biovista
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bitterroot Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Blacksmith Medicines
INFO:enrichment.clinicaltrials_client:NO TRIALS: Block Drug
INFO:enrichment.clinicaltrials_client:CLINICAL: Bloom Science -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 480/2483 (19.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: BlossomHill Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BlueArc Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: BlueJay Therapeutics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Bodyport -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Boehringer Ingelheim -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Bolt Biotherapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Bolt Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Bone Health Technologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Boomerang Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bora Biologics
INFO:enrichment.clinicaltrials_client:Progress: 490/2483 (19.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Borvo Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Boster Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Boston Scientific -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Boundless Bio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BrainKey
INFO:enrichment.clinicaltrials_client:NO TRIALS: Braveheart Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Brenig Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Brevet
INFO:enrichment.clinicaltrials_client:CLINICAL: BridGene Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: BridgeBio Oncology Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 500/2483 (20.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: BridgeBio Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: Bright Cell -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Bright Uro -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BrightInsight
INFO:enrichment.clinicaltrials_client:CLINICAL: Brii Biosciences -> 12 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Brink Biologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Brinter
INFO:enrichment.clinicaltrials_client:CLINICAL: Bristol Myers Squibb -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BroadPharm
INFO:enrichment.clinicaltrials_client:NO TRIALS: Broadwing Bio
INFO:enrichment.clinicaltrials_client:Progress: 510/2483 (20.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Broncus Medical -> 11 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: BryoLogyx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Bullseye Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Buto
INFO:enrichment.clinicaltrials_client:NO TRIALS: Butterfly Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Butterfly Network -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: C.Light Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: CAGE Bio -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CB Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CBCC Global Research
INFO:enrichment.clinicaltrials_client:Progress: 520/2483 (20.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: CDR3 Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CERo Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CF PharmTech
INFO:enrichment.clinicaltrials_client:CLINICAL: CG Oncology -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CGT Global
INFO:enrichment.clinicaltrials_client:NO TRIALS: CHO-plus
INFO:enrichment.clinicaltrials_client:NO TRIALS: CMR Naviscan
INFO:enrichment.clinicaltrials_client:NO TRIALS: CPC Scientific
INFO:enrichment.clinicaltrials_client:NO TRIALS: CPTx
INFO:enrichment.clinicaltrials_client:NO TRIALS: CRISPR QC
INFO:enrichment.clinicaltrials_client:Progress: 530/2483 (21.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: CS Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: CSL Behring -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CSL Plasma
INFO:enrichment.clinicaltrials_client:NO TRIALS: CTK Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: CURE Pharmaceutical
INFO:enrichment.clinicaltrials_client:NO TRIALS: CYMD
INFO:enrichment.clinicaltrials_client:NO TRIALS: CYP450-GP
INFO:enrichment.clinicaltrials_client:NO TRIALS: CYTORUM
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cache DNA
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cairn Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 540/2483 (21.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: CalBiotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: CalChem Synthesis
INFO:enrichment.clinicaltrials_client:CLINICAL: Cala Health -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CalciMedica -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Caldera Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Calico -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Calidi Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Calyxo -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cambrex Corporation
INFO:enrichment.clinicaltrials_client:CLINICAL: Camino Pharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 550/2483 (22.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Canary Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Candid Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cannabis Science
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cannuflow
INFO:enrichment.clinicaltrials_client:CLINICAL: Canon Medical Systems -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cantabio Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cantata Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Capacity Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Capienda Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Capricor Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 560/2483 (22.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Capsida Biotherapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CapsoVision -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Capstan Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Capulus Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Carbiotix
INFO:enrichment.clinicaltrials_client:CLINICAL: Cardiff Oncology -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CardioDiagnostics
INFO:enrichment.clinicaltrials_client:CLINICAL: CareDx -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Caribou Biosciences -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Carl Zeiss Meditec -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 570/2483 (23.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Carlsbad Technology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Carlsmed
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cartography Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Cassava Sciences -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Catalyst Pharmaceuticals -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Catena Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: CathWorks -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cel-Sci Corporation -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CeleCor Therapeutics -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Celestial Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 580/2483 (23.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cell Applications
INFO:enrichment.clinicaltrials_client:CLINICAL: Cell Biolabs -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cell Care Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cell Marque
INFO:enrichment.clinicaltrials_client:NO TRIALS: CellFE
INFO:enrichment.clinicaltrials_client:NO TRIALS: CellMP
INFO:enrichment.clinicaltrials_client:CLINICAL: CellMax Life -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: CellSight Technologies -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CellXLife
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellanome
INFO:enrichment.clinicaltrials_client:Progress: 590/2483 (23.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellarcus Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellares
INFO:enrichment.clinicaltrials_client:NO TRIALS: CellarisBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellastra
INFO:enrichment.clinicaltrials_client:NO TRIALS: Celldom
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellecta
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellentia
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellgen Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellics Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Cello Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 600/2483 (24.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellsonics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Celltheon
INFO:enrichment.clinicaltrials_client:NO TRIALS: Celltrio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cellular Vehicles
INFO:enrichment.clinicaltrials_client:CLINICAL: Cellworks -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Celprogen
INFO:enrichment.clinicaltrials_client:NO TRIALS: CenExel Clinical Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cencora
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cenna Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Centivax
INFO:enrichment.clinicaltrials_client:Progress: 610/2483 (24.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Centricity Vision -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Centrillion Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Cepheid -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ceragenix Pharmaceuticals -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cerebra AI
INFO:enrichment.clinicaltrials_client:CLINICAL: Cerevel Therapeutics -> 20 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ceribell -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Certis Oncology Solutions -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cerus -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cessation Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 620/2483 (25.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chai Discovery
INFO:enrichment.clinicaltrials_client:CLINICAL: Channel Medsystems -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chanshow Biotechnology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chantibody
INFO:enrichment.clinicaltrials_client:CLINICAL: Character Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Charles River Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: ChemDiv
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chembridge Corporation
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chemveda Life Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chimera Bioengineering
INFO:enrichment.clinicaltrials_client:Progress: 630/2483 (25.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ChromaCode
INFO:enrichment.clinicaltrials_client:NO TRIALS: Chrysalis Biomedical Advisors
INFO:enrichment.clinicaltrials_client:CLINICAL: Cidara Therapeutics -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CinderBio
INFO:enrichment.clinicaltrials_client:CLINICAL: Cipherome -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Circle Pharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cirsium Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cirtec Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cisterna Biologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Civica Rx
INFO:enrichment.clinicaltrials_client:Progress: 640/2483 (25.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Clara Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Claremont BioSolutions
INFO:enrichment.clinicaltrials_client:NO TRIALS: Claret Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Clarity Genomics -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Clear Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: ClearFlow -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ClearNote Health -> 3 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: ClearPath Surgical
INFO:enrichment.clinicaltrials_client:NO TRIALS: ClearPoint Neuro
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cleo Life Sciences
INFO:enrichment.clinicaltrials_client:Progress: 650/2483 (26.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Climax Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: ClinDatrix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cliniqa
INFO:enrichment.clinicaltrials_client:CLINICAL: Clinuvel Pharmaceuticals -> 20 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CloudCath -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cloudbreak Pharmaceutical -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Clovis Oncology -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CoA Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CoaguSense
INFO:enrichment.clinicaltrials_client:NO TRIALS: Coagulant Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 660/2483 (26.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Coastar Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Codexis -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cognixion -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cognos Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cognuse Neuroscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Coherence Neuro
INFO:enrichment.clinicaltrials_client:CLINICAL: Coherus Oncology -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Collaborative Clinical Research Consulting
INFO:enrichment.clinicaltrials_client:NO TRIALS: Collaborative Drug Discovery
INFO:enrichment.clinicaltrials_client:CLINICAL: Color -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 670/2483 (27.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Combe Incorporated
INFO:enrichment.clinicaltrials_client:NO TRIALS: Compact Cath
INFO:enrichment.clinicaltrials_client:CLINICAL: Comparative Biosciences -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Complete Genomics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Compugen -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ConKay Medical Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: Concentric Analgesics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Conception -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Concuir Consulting
INFO:enrichment.clinicaltrials_client:NO TRIALS: Confidence Pharmaceutical Research
INFO:enrichment.clinicaltrials_client:Progress: 680/2483 (27.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Confluent Medical Technologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ConfometRx
INFO:enrichment.clinicaltrials_client:CLINICAL: Contineum Therapeutics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Convergent Genomics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cooler Heads -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Copan Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: CorDx
INFO:enrichment.clinicaltrials_client:CLINICAL: Corcept Therapeutics -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cordance Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Corentec
INFO:enrichment.clinicaltrials_client:Progress: 690/2483 (27.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Cornea Biosciences -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Correlia Biosystems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Corsair Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cortechs.ai
INFO:enrichment.clinicaltrials_client:CLINICAL: Cortex -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cortigent
INFO:enrichment.clinicaltrials_client:CLINICAL: Corvus Pharmaceuticals -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cosmo Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Cothera Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Countable Labs
INFO:enrichment.clinicaltrials_client:Progress: 700/2483 (28.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Counterpoint Biomedica
INFO:enrichment.clinicaltrials_client:NO TRIALS: CovarsaDx
INFO:enrichment.clinicaltrials_client:CLINICAL: Create Biosciences -> 12 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Credence MedSystems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Creyon Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Crinetics Pharmaceuticals -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CrossBay Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Crown Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Crystalys Therapeutics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cubit Diagnostics
INFO:enrichment.clinicaltrials_client:Progress: 710/2483 (28.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Cullgen -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Culture Biosciences -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cura Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: CuraSen Therapeutics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: CureMetrix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Curebase
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cureline
INFO:enrichment.clinicaltrials_client:NO TRIALS: Curematch
ERROR:enrichment.clinicaltrials_client:Failed to search trials for Curia (): 400 Client Error: Bad Request for url: https://clinicaltrials.gov/api/v2/studies?query.spons=Curia+%28%29&pageSize=50&format=json
ERROR:enrichment.clinicaltrials_client:Response status: 400
ERROR:enrichment.clinicaltrials_client:Response text: Error parsing query in Sponsor / collaborator: inner bool query clause cannot be null
ERROR:enrichment.clinicaltrials_client:Failed to search trials for Curia (), Inc.: 400 Client Error: Bad Request for url: https://clinicaltrials.gov/api/v2/studies?query.spons=Curia+%28%29%2C+Inc.&pageSize=50&format=json
ERROR:enrichment.clinicaltrials_client:Response status: 400
ERROR:enrichment.clinicaltrials_client:Response text: Error parsing query in Sponsor / collaborator: extraneous input ')' expecting {'(', ',', 'NOT', 'SEARCH', 'AREA', 'RANGE', 'DISTANCE', Coverage, Expansion, 'TILT', 'ALL', 'MISSING', 'MIN', 'MAX', EscapedKeyword, BooleanLiteral, DecimalLiteral, DateLiteral, TimeLiteral, RadiusLiteral, StringLiteral, Term}
no viable alternative at input 'Inc.'
missing ')' at '<EOF>'
ERROR:enrichment.clinicaltrials_client:Failed to search trials for Curia () Inc: 400 Client Error: Bad Request for url: https://clinicaltrials.gov/api/v2/studies?query.spons=Curia+%28%29+Inc&pageSize=50&format=json
ERROR:enrichment.clinicaltrials_client:Response status: 400
ERROR:enrichment.clinicaltrials_client:Response text: Error parsing query in Sponsor / collaborator: extraneous input ')' expecting {'(', ',', 'NOT', 'SEARCH', 'AREA', 'RANGE', 'DISTANCE', Coverage, Expansion, 'TILT', 'ALL', 'MISSING', 'MIN', 'MAX', EscapedKeyword, BooleanLiteral, DecimalLiteral, DateLiteral, TimeLiteral, RadiusLiteral, StringLiteral, Term}
missing ')' at '<EOF>'
INFO:enrichment.clinicaltrials_client:NO TRIALS: Curia (company)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Curio Bioscience
INFO:enrichment.clinicaltrials_client:Progress: 720/2483 (29.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Curve Biosciences -> 16 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cyagen Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Cyclarity Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cypre
INFO:enrichment.clinicaltrials_client:CLINICAL: Cystetic Medicines -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: CytRx -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cytek Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: CytoImmune Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Cytokinetics -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cytologics
INFO:enrichment.clinicaltrials_client:Progress: 730/2483 (29.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: CytomX Therapeutics -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Cytonus Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Cytovale -> 2 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: DC3 Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: DCN Dx
INFO:enrichment.clinicaltrials_client:NO TRIALS: DDL
INFO:enrichment.clinicaltrials_client:NO TRIALS: DNA Compass
INFO:enrichment.clinicaltrials_client:NO TRIALS: DNAe
INFO:enrichment.clinicaltrials_client:NO TRIALS: DNAnexus
INFO:enrichment.clinicaltrials_client:CLINICAL: Da Zen Theranostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 740/2483 (29.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Dalton Bioanalytics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Danco Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Danner Laboratory
INFO:enrichment.clinicaltrials_client:NO TRIALS: Dark Horse Consulting
INFO:enrichment.clinicaltrials_client:NO TRIALS: Darmiyan
INFO:enrichment.clinicaltrials_client:CLINICAL: DarÃ© Bioscience -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Day One Biopharmaceuticals -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: De Novo Software
INFO:enrichment.clinicaltrials_client:NO TRIALS: Deciduous Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Decipher Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 750/2483 (30.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Decision Sciences Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Deep 6 AI
INFO:enrichment.clinicaltrials_client:NO TRIALS: Deep Apple Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: DeepSight Technology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Deepcell
INFO:enrichment.clinicaltrials_client:CLINICAL: Defined Bioscience -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Degron Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: DelNova
INFO:enrichment.clinicaltrials_client:NO TRIALS: Delix Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Delpor -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 760/2483 (30.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Delve Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Denali Therapeutics -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Dendreon -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Denovicon Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Denovo Biopharma -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: DermTech -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Dermata Therapeutics -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Design Therapeutics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Dexcom -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Dextera Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 770/2483 (31.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: DiNAQOR
INFO:enrichment.clinicaltrials_client:CLINICAL: DiaCarta -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Diablo Clinical Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: Diadem Biotherapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Diagnologix
INFO:enrichment.clinicaltrials_client:CLINICAL: Diagnostic BioSystems -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Diality -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Diazyme Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Differentia Biotech
INFO:enrichment.clinicaltrials_client:CLINICAL: Diffuse Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 780/2483 (31.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Diffusion Pharmaceuticals -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Discover Echo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Dispatch Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Dow Development Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: Dren Bio -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Dualitas Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Duke Empirical
INFO:enrichment.clinicaltrials_client:CLINICAL: Durect -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: DxTerity -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: DyAnsys -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 790/2483 (31.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Dynavax Technologies -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Dyve Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: EAG Laboratories
INFO:enrichment.clinicaltrials_client:CLINICAL: EBR Systems -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: EGeen
INFO:enrichment.clinicaltrials_client:CLINICAL: EOC Pharma -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: EPOK Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: EV Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: EXONBIO
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eargo
INFO:enrichment.clinicaltrials_client:Progress: 800/2483 (32.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Earli
INFO:enrichment.clinicaltrials_client:NO TRIALS: EarlyDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: EchoPixel
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eclipse Bioinnovations
INFO:enrichment.clinicaltrials_client:CLINICAL: Eclipse Regenesis -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Edan Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Edge BioSystems -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: EditCo Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Editas Medicine -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Editpep
INFO:enrichment.clinicaltrials_client:Progress: 810/2483 (32.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Edwards Lifesciences -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Efemoral Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: EicOsis -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eicos Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eidogen-Sertanty
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eigen Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Eikon Therapeutics -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Eko Devices -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ekso Bionics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Elanco
INFO:enrichment.clinicaltrials_client:Progress: 820/2483 (33.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Electra Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Eledon Pharmaceuticals -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Elegen
INFO:enrichment.clinicaltrials_client:CLINICAL: Element -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Element Biosciences -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Element Science -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Elevalue Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Elevate Movement
INFO:enrichment.clinicaltrials_client:NO TRIALS: Elevation Spine
INFO:enrichment.clinicaltrials_client:CLINICAL: Eli Lilly -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 830/2483 (33.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eliaz Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Elim Biopharm
INFO:enrichment.clinicaltrials_client:CLINICAL: Elios Vision -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eliquent Life Sciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Elixir Medical -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Elpida Therapeutics -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eluciderm
INFO:enrichment.clinicaltrials_client:CLINICAL: Elutia -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Emboline -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Embolx
INFO:enrichment.clinicaltrials_client:Progress: 840/2483 (33.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Emergent BioSolutions -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: EmeritusDX
INFO:enrichment.clinicaltrials_client:NO TRIALS: Emerzene
INFO:enrichment.clinicaltrials_client:NO TRIALS: Emmaus Life Sciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Emmecell -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Empirical Spine -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Empirico
INFO:enrichment.clinicaltrials_client:NO TRIALS: EnGen Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Enable Biosciences -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Enable Medicine
INFO:enrichment.clinicaltrials_client:Progress: 850/2483 (34.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Enabled Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Encellin -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Encoded Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Encodia
INFO:enrichment.clinicaltrials_client:CLINICAL: Encoll -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Endeavor BioMedicines -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Endiatx -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: EndoCyclic Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Endocrine Technologies -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Endocyte -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 860/2483 (34.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Endogena Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Endologix -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Endometrics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Endonovo Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Endovascular Engineering -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Endpoint Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Endurance Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Endure Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Engage Bio -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Engine Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 870/2483 (35.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Engrail Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Enlaza Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Enoda Cellworks
INFO:enrichment.clinicaltrials_client:NO TRIALS: EnquBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ensho Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ensigna Biosystems
INFO:enrichment.clinicaltrials_client:CLINICAL: Enspectra Health -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ensysce Biosciences -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Entelexo Biotherapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Enterey
INFO:enrichment.clinicaltrials_client:Progress: 880/2483 (35.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: EntroGen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Enviroflo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eolo Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: Epalex
INFO:enrichment.clinicaltrials_client:NO TRIALS: EpiBiologics
INFO:enrichment.clinicaltrials_client:CLINICAL: EpicentRx -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Epicrispr Biotechnologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Epigen Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Epinex Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Epinoma
INFO:enrichment.clinicaltrials_client:Progress: 890/2483 (35.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Epiodyne
INFO:enrichment.clinicaltrials_client:CLINICAL: Epirium Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Epitope Diagnostics
INFO:enrichment.clinicaltrials_client:CLINICAL: Equillium -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Erasca -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ermaris Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ernexa Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Escient Pharmaceuticals -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Esperion Therapeutics -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Esperto Medical
INFO:enrichment.clinicaltrials_client:Progress: 900/2483 (36.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Estrella Immunopharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Etaluma
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eton Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eugit Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eumentis Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Eureka Therapeutics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Evercrisp Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Everest Detection -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Evidation Health -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Evident Vascular
INFO:enrichment.clinicaltrials_client:Progress: 910/2483 (36.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Evofem Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Evoke Pharma -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Evommune -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ExThera Medical -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Exact Sciences Corp. -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Exagen Diagnostics
INFO:enrichment.clinicaltrials_client:CLINICAL: Exai Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Excellergy
INFO:enrichment.clinicaltrials_client:NO TRIALS: Excellos
INFO:enrichment.clinicaltrials_client:NO TRIALS: Exceltox Laboratories
INFO:enrichment.clinicaltrials_client:Progress: 920/2483 (37.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ExcepGen
INFO:enrichment.clinicaltrials_client:CLINICAL: Excision BioTherapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Exelixis -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Exo Imaging
INFO:enrichment.clinicaltrials_client:CLINICAL: Expanding Innovations -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Expanesthetics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Expert Chemical Analysis
INFO:enrichment.clinicaltrials_client:NO TRIALS: Expert Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: Exploratory Science Center -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Expression Systems -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:Progress: 930/2483 (37.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Eyconis
INFO:enrichment.clinicaltrials_client:CLINICAL: EyePoint Pharmaceuticals -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Eyenuk -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Eysz -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: FAScinate Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: FFA Sciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: FLAVORx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fabre-Kramer Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fabric Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Factorial Biotechnologies
INFO:enrichment.clinicaltrials_client:Progress: 940/2483 (37.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Faeth Therapeutics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Farbridge Pharma Consulting
INFO:enrichment.clinicaltrials_client:CLINICAL: Fate Therapeutics -> 20 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fauna Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Fe Pharmaceuticals -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: FemCap
INFO:enrichment.clinicaltrials_client:NO TRIALS: FemDx Medsystems
INFO:enrichment.clinicaltrials_client:NO TRIALS: FemtoDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ferrum Health
INFO:enrichment.clinicaltrials_client:CLINICAL: FibrAlign -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 950/2483 (38.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: FibroGen -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Field Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Firefly Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fist Assist Devices
INFO:enrichment.clinicaltrials_client:NO TRIALS: Flexion Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Flightpath Biosciences -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Florica Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fluxergy
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fluxus
INFO:enrichment.clinicaltrials_client:CLINICAL: Foothill Scientific Associates -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 960/2483 (38.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Forcyte Biotechnologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: FormuMax
INFO:enrichment.clinicaltrials_client:NO TRIALS: Formurex
INFO:enrichment.clinicaltrials_client:CLINICAL: Fortis Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fortress Biotech
INFO:enrichment.clinicaltrials_client:CLINICAL: Fountain Therapeutics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Fractyl Health -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Freedom Biosciences -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Freenome -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Freudenberg Medical
INFO:enrichment.clinicaltrials_client:Progress: 970/2483 (39.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Frontage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Frontier Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Frontier Medicines -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fujifilm Diosynth
INFO:enrichment.clinicaltrials_client:CLINICAL: Fujirebio Diagnostics -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Fulgent Genetics
INFO:enrichment.clinicaltrials_client:CLINICAL: Fulgent Pharma -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: FzioMed -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: G-Tech Medical -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: G.F. Harvey Company
INFO:enrichment.clinicaltrials_client:Progress: 980/2483 (39.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: GABAeron
INFO:enrichment.clinicaltrials_client:NO TRIALS: GATC Health
INFO:enrichment.clinicaltrials_client:CLINICAL: GE HealthCare -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: GEn1E Lifesciences -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: GIOSTAR
INFO:enrichment.clinicaltrials_client:CLINICAL: GL Technologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: GRAIL -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: GRI Bio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: GT Apeiron
INFO:enrichment.clinicaltrials_client:CLINICAL: GT Biopharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 990/2483 (39.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: GTx Incorporated -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gaba Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Galena Biopharma -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Galvani Bioelectronics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Galvanize Therapeutics -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ganymede
INFO:enrichment.clinicaltrials_client:NO TRIALS: Garner Biosolutions
INFO:enrichment.clinicaltrials_client:CLINICAL: Gate Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gator Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gel Company
INFO:enrichment.clinicaltrials_client:Progress: 1000/2483 (40.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: GemPharmatech
INFO:enrichment.clinicaltrials_client:CLINICAL: Gemini Bio -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenBody
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenCirq
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenEdit
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenEndeavor
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenNext Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenTarget
INFO:enrichment.clinicaltrials_client:CLINICAL: GenVivo -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1010/2483 (40.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: GenZum Life Sciences -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Genalyte
INFO:enrichment.clinicaltrials_client:CLINICAL: Genascence -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gencyte Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: GeneGenieDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: GeneMed Biotechnologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: GeneTex
INFO:enrichment.clinicaltrials_client:NO TRIALS: Genefab
INFO:enrichment.clinicaltrials_client:CLINICAL: Genelux -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Genentech -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 1020/2483 (41.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gener8
INFO:enrichment.clinicaltrials_client:NO TRIALS: General Cardiac Technology
INFO:enrichment.clinicaltrials_client:NO TRIALS: General Proximity
INFO:enrichment.clinicaltrials_client:NO TRIALS: Generate:Biomedicines
INFO:enrichment.clinicaltrials_client:CLINICAL: Genervon -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Genervon Biopharmaceuticals -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Genesis Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: GenexGen
INFO:enrichment.clinicaltrials_client:CLINICAL: Genomatica -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Genomic Testing Cooperative -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1030/2483 (41.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Genoox
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gentech Pharmaceutical
INFO:enrichment.clinicaltrials_client:CLINICAL: Geron -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: GigaGen -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: GigaMune
INFO:enrichment.clinicaltrials_client:CLINICAL: Gilead -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gilero
INFO:enrichment.clinicaltrials_client:CLINICAL: Gilgamesh Pharmaceuticals -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ginolis
INFO:enrichment.clinicaltrials_client:NO TRIALS: Girihlet
INFO:enrichment.clinicaltrials_client:Progress: 1040/2483 (41.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Glaukos -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Global Cancer Technology
INFO:enrichment.clinicaltrials_client:CLINICAL: Glooko -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: GlycoMinds -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Glycomine -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Glycyx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Golden West Biologicals
INFO:enrichment.clinicaltrials_client:NO TRIALS: GondolaBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gordian Biotechnology
INFO:enrichment.clinicaltrials_client:CLINICAL: Gossamer Bio -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1050/2483 (42.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Grace Science -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Grand River Aseptic Manufacturing
INFO:enrichment.clinicaltrials_client:NO TRIALS: Grann Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Gravitas Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Greenstone Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Grifols -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gryphon Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Guardant Health -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gyder Surgical
INFO:enrichment.clinicaltrials_client:CLINICAL: Gynesonics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1060/2483 (42.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Gyre Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: HAYA Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: HD Medical
INFO:enrichment.clinicaltrials_client:CLINICAL: HK Surgical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: HOPO Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: HORIBA Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: HTD Biosystems
INFO:enrichment.clinicaltrials_client:NO TRIALS: HUGENX
INFO:enrichment.clinicaltrials_client:CLINICAL: Hallux -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Halo Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 1070/2483 (43.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Halozyme Therapeutics -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hand Biomechanics Lab
INFO:enrichment.clinicaltrials_client:CLINICAL: Handa Pharmaceuticals -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Harbor MedTech
INFO:enrichment.clinicaltrials_client:CLINICAL: Hardy Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Harrow Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hawkeye Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: HealthBio AI
INFO:enrichment.clinicaltrials_client:CLINICAL: HeartBeam -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: HeartFlow -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1080/2483 (43.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Helicore Biopharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Helio Genomics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Helix -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Help Remedies
INFO:enrichment.clinicaltrials_client:NO TRIALS: HepaTx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Herophilus
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hexagon Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hikari Medical Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Hillhurst Biopharmaceuticals -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hinge Bio
INFO:enrichment.clinicaltrials_client:Progress: 1090/2483 (43.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Hinge Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Histologics
INFO:enrichment.clinicaltrials_client:CLINICAL: Holoclara -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Hologic -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hongene Biotech Corporation
INFO:enrichment.clinicaltrials_client:NO TRIALS: Horiba Instruments
INFO:enrichment.clinicaltrials_client:CLINICAL: Horizon Surgical Systems -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hospi Corporation
INFO:enrichment.clinicaltrials_client:CLINICAL: Hospira -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Human Longevity
INFO:enrichment.clinicaltrials_client:Progress: 1100/2483 (44.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Humanity Neurotech
INFO:enrichment.clinicaltrials_client:CLINICAL: Huya Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Hycor Biomedical
INFO:enrichment.clinicaltrials_client:NO TRIALS: HypO2Regen
INFO:enrichment.clinicaltrials_client:NO TRIALS: I Peace
INFO:enrichment.clinicaltrials_client:CLINICAL: ICU Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: IDEAYA Biosciences -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: IFM Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: IGeneX
INFO:enrichment.clinicaltrials_client:NO TRIALS: IHP Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1110/2483 (44.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: IMIDomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: INOMIXO
INFO:enrichment.clinicaltrials_client:CLINICAL: IPS HEART -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: IQVIA
INFO:enrichment.clinicaltrials_client:NO TRIALS: IRIDEX
INFO:enrichment.clinicaltrials_client:NO TRIALS: ISTA Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Iambic Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ichor Medical Systems -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: IconOVir Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Idience -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1120/2483 (45.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: IgGenix -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Igenomix -> 16 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Illumina -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Illuminant Surgical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Imagene
INFO:enrichment.clinicaltrials_client:CLINICAL: ImaginAb -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Immix Biopharma -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Immune Inc. -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Immune-Onc Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ImmuneBridge
INFO:enrichment.clinicaltrials_client:Progress: 1130/2483 (45.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Immunicom -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Immunis -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ImmunityBio -> 18 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Immuno Concepts
INFO:enrichment.clinicaltrials_client:NO TRIALS: ImmunoMind
INFO:enrichment.clinicaltrials_client:NO TRIALS: ImmunoVec
INFO:enrichment.clinicaltrials_client:NO TRIALS: ImmunoVision
INFO:enrichment.clinicaltrials_client:NO TRIALS: Immunova Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Imorgon
INFO:enrichment.clinicaltrials_client:CLINICAL: Imperative Care -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1140/2483 (45.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Impilo Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Implen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Imvaria
INFO:enrichment.clinicaltrials_client:CLINICAL: InCarda Therapeutics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: InClin
INFO:enrichment.clinicaltrials_client:CLINICAL: InVivoScribe -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Inapill
INFO:enrichment.clinicaltrials_client:CLINICAL: Inari Medical -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Inceptive
INFO:enrichment.clinicaltrials_client:CLINICAL: Incyte -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 1150/2483 (46.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Indapta Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Indee Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Indi Molecular
INFO:enrichment.clinicaltrials_client:CLINICAL: Induce Biologics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Infinant Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Infinimmune
INFO:enrichment.clinicaltrials_client:NO TRIALS: Infinity Neuro
INFO:enrichment.clinicaltrials_client:NO TRIALS: Infixion Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Inflammatix -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Inhibrx Biosciences -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1160/2483 (46.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Initial Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: InjectSense
INFO:enrichment.clinicaltrials_client:NO TRIALS: Inkspace Imaging
INFO:enrichment.clinicaltrials_client:NO TRIALS: InnoPep
INFO:enrichment.clinicaltrials_client:NO TRIALS: Innophore
INFO:enrichment.clinicaltrials_client:CLINICAL: Innova Vascular -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Innovative Device Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Innovative NeuroTechnologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Innovex Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Innovo Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1170/2483 (47.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Inocras -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Inovio Pharmaceuticals -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Inquis Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Insamo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Inscopix
INFO:enrichment.clinicaltrials_client:NO TRIALS: InsightRX
INFO:enrichment.clinicaltrials_client:CLINICAL: Intact Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Intarcia Therapeutics -> 20 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Integra LifeSciences -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Integrated Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1180/2483 (47.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Integrated Endoscopy
INFO:enrichment.clinicaltrials_client:NO TRIALS: Integrated Research Associates
INFO:enrichment.clinicaltrials_client:CLINICAL: Intellia Therapeutics -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Intelligent Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: InterVene -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: InterVenn BioSciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Intercept Pharmaceuticals -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Interdict
INFO:enrichment.clinicaltrials_client:NO TRIALS: International Process Solutions
INFO:enrichment.clinicaltrials_client:CLINICAL: International Stem Cell -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 1190/2483 (47.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Intraop Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Intratus
INFO:enrichment.clinicaltrials_client:CLINICAL: Intrinsic LifeSciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Intuitive Surgical -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Intune
INFO:enrichment.clinicaltrials_client:NO TRIALS: InvVax
INFO:enrichment.clinicaltrials_client:CLINICAL: Invenio Imaging -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Invert
INFO:enrichment.clinicaltrials_client:CLINICAL: Invicta Medical -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Invitrx Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1200/2483 (48.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: InvivoGen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Iolyx Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ion Dx
INFO:enrichment.clinicaltrials_client:CLINICAL: Ionis Pharmaceuticals -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Iovance Biotherapeutics -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Iris Medicine
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ironfist Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Irvine Clinical Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: Isolation Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: JADBio
INFO:enrichment.clinicaltrials_client:Progress: 1210/2483 (48.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: JOINN Biologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: JSR Life Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Jaan Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Jade Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: JadeBio
INFO:enrichment.clinicaltrials_client:CLINICAL: Janux Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Jasper Therapeutics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Jaya Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Jazz Pharmaceuticals -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: JenaValve -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1220/2483 (49.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: JeniVision -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Johnson & Johnson -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Johnson and Johnson Innovative Medicine
INFO:enrichment.clinicaltrials_client:CLINICAL: Jones Pharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Jumpcode Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Junevity
INFO:enrichment.clinicaltrials_client:CLINICAL: Jupiter Endovascular -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Juvena Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: KARE Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: KARL STORZ Endoscopy
INFO:enrichment.clinicaltrials_client:Progress: 1230/2483 (49.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: KB Medical Group
INFO:enrichment.clinicaltrials_client:CLINICAL: KC Pharma -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: KDx Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: KHN Solutions/BACTrack
INFO:enrichment.clinicaltrials_client:CLINICAL: Kadmon Corporation -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kaer Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Kailera Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kainomyx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kairos Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: KaloBios Pharmaceuticals
INFO:enrichment.clinicaltrials_client:Progress: 1240/2483 (49.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Kamau Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: KannaLife
INFO:enrichment.clinicaltrials_client:CLINICAL: Kardigan -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Karius -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Kartos Therapeutics -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Karuna Labs -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kelaroo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kelliop
INFO:enrichment.clinicaltrials_client:CLINICAL: Kenai Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: KeraMed -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:Progress: 1250/2483 (50.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kerna Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: Kernel Flow -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Keylika
INFO:enrichment.clinicaltrials_client:CLINICAL: Kezar Life Sciences -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Khloris Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kimia Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Kinamed -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kinetic Concepts
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kinovate
INFO:enrichment.clinicaltrials_client:CLINICAL: Kiora Pharmaceuticals -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1260/2483 (50.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kite Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: Kivu Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: KlyneAI
INFO:enrichment.clinicaltrials_client:CLINICAL: Kodiak Sciences -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Koliber Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Konan Medical
INFO:enrichment.clinicaltrials_client:CLINICAL: Koya Medical -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Kriya Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kryptos Biotechnologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Kumquat Biosciences -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1270/2483 (51.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Kura Oncology -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: KuriBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Kurin
INFO:enrichment.clinicaltrials_client:CLINICAL: Kyowa Hakko Kirin -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Kyverna Therapeutics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: LENZ Therapeutics -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: LGC Biosearch Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: LGM Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: LIPAC Oncology -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: LTZ Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1280/2483 (51.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: LabyRx Immuno-Oncology
INFO:enrichment.clinicaltrials_client:NO TRIALS: LadRx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Laguna Biotherapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Laguna Tech
INFO:enrichment.clinicaltrials_client:CLINICAL: Lassen Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lassogen
INFO:enrichment.clinicaltrials_client:NO TRIALS: LatchBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Latent Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: LatentSpace Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Latigo Biotherapeutics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1290/2483 (52.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Latitude Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Laza Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: LeGene Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Leaf Healthcare -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Leapfrog Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Leardon Solutions
INFO:enrichment.clinicaltrials_client:NO TRIALS: Leiner Health Products
INFO:enrichment.clinicaltrials_client:NO TRIALS: Leucadia Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Level Zero Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Levena Biopharma
INFO:enrichment.clinicaltrials_client:Progress: 1300/2483 (52.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Levita Magnetics -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: LevitasBio
INFO:enrichment.clinicaltrials_client:CLINICAL: Lexicon Pharmaceuticals -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: LiVeritas Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Libra Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Life Science Outsourcing
INFO:enrichment.clinicaltrials_client:NO TRIALS: LifeActive Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: LifeScience PLUS -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: LifeSpan Biosciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: LifeWave Biomedical
INFO:enrichment.clinicaltrials_client:Progress: 1310/2483 (52.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Liferiver Bio-Tech Corp
INFO:enrichment.clinicaltrials_client:NO TRIALS: Liferna Biotech
INFO:enrichment.clinicaltrials_client:CLINICAL: Ligand Pharmaceuticals -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Light Horse Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Lighthouse Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: LimFlow -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Limb Preservation Platform
INFO:enrichment.clinicaltrials_client:NO TRIALS: LinaTech
INFO:enrichment.clinicaltrials_client:CLINICAL: Lineage Cell Therapeutics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Link Cell Therapies
INFO:enrichment.clinicaltrials_client:Progress: 1320/2483 (53.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Linnaeus Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lipidio Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Liquid Biosciences -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: List Biological Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: List of biotech and pharmaceutical companies in the New York metropolitan area
INFO:enrichment.clinicaltrials_client:NO TRIALS: List of companies based in the San Francisco Bay Area
INFO:enrichment.clinicaltrials_client:NO TRIALS: Livionex Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: Lixte Biotechnology -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Locus Biosciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Lonza -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1330/2483 (53.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Lotus Clinical Research -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lucina Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Lumenis -> 17 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: LumiQuick Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Luminary Genetics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Luminyst
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lumiphore
INFO:enrichment.clinicaltrials_client:CLINICAL: Lumos Diagnostics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Luna Diabetes -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lunai Bioworks
INFO:enrichment.clinicaltrials_client:Progress: 1340/2483 (54.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lundbeck Seattle Biopharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: LungLife AI -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lusis
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lusis Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lycia Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Lyell Immunopharma -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lygos
INFO:enrichment.clinicaltrials_client:CLINICAL: Lykos Therapeutics -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lynx Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Lyterian Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1350/2483 (54.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: M3 Wake Research
INFO:enrichment.clinicaltrials_client:CLINICAL: MAST Biosurgery -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: MAX BioPharma -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: MBrace Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MCLAB
INFO:enrichment.clinicaltrials_client:CLINICAL: MDxHealth -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: MP Biomedicals -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MabSwitch
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mablytics
INFO:enrichment.clinicaltrials_client:CLINICAL: Machaon Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1360/2483 (54.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Macro Biologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: MagQu
INFO:enrichment.clinicaltrials_client:NO TRIALS: Magic Lifescience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Magnetic Insight
INFO:enrichment.clinicaltrials_client:CLINICAL: Magnus Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Mahzi Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Maipl Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Makani Science -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MakroCare
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mammoth Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 1370/2483 (55.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: MannKind -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MantleBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Manzanita Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mapp Biopharmaceutical
INFO:enrichment.clinicaltrials_client:NO TRIALS: MarWell Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Marathon Pharmaceuticals -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Marea Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Marin Biologic Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Marman Industries
INFO:enrichment.clinicaltrials_client:CLINICAL: Masimo -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1380/2483 (55.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Materna Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MatriSys Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Matrigen Life Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Matrix Biomed -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Matrubials
INFO:enrichment.clinicaltrials_client:NO TRIALS: Maverix Biomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mawi DNA Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Maxwell Biomedical -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Maxygen (2) -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Maxymune Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1390/2483 (56.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Maze Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: McGuff Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: McKesson Corporation
INFO:enrichment.clinicaltrials_client:CLINICAL: McNeil Consumer Healthcare -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MeCo Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Meacor
INFO:enrichment.clinicaltrials_client:NO TRIALS: Meadowhawk Biolabs
INFO:enrichment.clinicaltrials_client:NO TRIALS: MedSpark
INFO:enrichment.clinicaltrials_client:CLINICAL: Medable -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Medeloop
INFO:enrichment.clinicaltrials_client:Progress: 1400/2483 (56.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Medeologix
INFO:enrichment.clinicaltrials_client:CLINICAL: Medeor Therapeutics -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MediCell Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: MediPines
INFO:enrichment.clinicaltrials_client:CLINICAL: MediPrint Ophthalmics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Medic Life Sciences -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Medical Instrument Development Laboratories
INFO:enrichment.clinicaltrials_client:CLINICAL: Medical Marijuana, Inc. -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: MediciNova -> 16 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Medikine -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1410/2483 (56.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Meditrina -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Medium Biosciences -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Medrio
INFO:enrichment.clinicaltrials_client:CLINICAL: Medrx -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Medtronic -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Meissner -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Melinta Therapeutics -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Melior Discovery
INFO:enrichment.clinicaltrials_client:NO TRIALS: Meliora Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Melzi Surgical
INFO:enrichment.clinicaltrials_client:Progress: 1420/2483 (57.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mendaera
INFO:enrichment.clinicaltrials_client:CLINICAL: Mentholatum -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Mercator MedSystems -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Merck -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Merial
INFO:enrichment.clinicaltrials_client:CLINICAL: Meridian Medical Technologies -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Merrimack Pharmaceuticals -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Metaba
INFO:enrichment.clinicaltrials_client:CLINICAL: Metabiomics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Metabolomycs
INFO:enrichment.clinicaltrials_client:Progress: 1430/2483 (57.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Metacrine -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Metagenomi
INFO:enrichment.clinicaltrials_client:CLINICAL: MiCareo -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Micro Medical Devices
INFO:enrichment.clinicaltrials_client:NO TRIALS: MicroPure Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: MicroRite
INFO:enrichment.clinicaltrials_client:NO TRIALS: MicrobeDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Microbiologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Microvascular Tissues
INFO:enrichment.clinicaltrials_client:CLINICAL: MicuRx Pharmaceuticals -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1440/2483 (58.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Miist Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mikroscan Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Milagen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Millipore
INFO:enrichment.clinicaltrials_client:NO TRIALS: MilliporeSigma
INFO:enrichment.clinicaltrials_client:CLINICAL: Miltenyi Biotec -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MindMed
INFO:enrichment.clinicaltrials_client:CLINICAL: MindRhythm -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Mindera -> 2 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Mindstate Design Labs -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1450/2483 (58.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Minerva Surgical -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: MingSight Pharmaceuticals -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Minotaur Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Minutia
INFO:enrichment.clinicaltrials_client:NO TRIALS: MiraDx
INFO:enrichment.clinicaltrials_client:CLINICAL: Mirador Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Miraomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Mirum Pharmaceuticals -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Mirvie -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mission Bio
INFO:enrichment.clinicaltrials_client:Progress: 1460/2483 (58.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mission Trail Biolabs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mithradote Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mithrl
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mitrix bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mizuho OSI
INFO:enrichment.clinicaltrials_client:NO TRIALS: Model Medicines
INFO:enrichment.clinicaltrials_client:NO TRIALS: Moderna
INFO:enrichment.clinicaltrials_client:CLINICAL: Modular Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Modulo Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Molecular Depot
INFO:enrichment.clinicaltrials_client:Progress: 1470/2483 (59.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Molecular Devices
INFO:enrichment.clinicaltrials_client:CLINICAL: Molecular Instruments -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Molecular Matrix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Molsoft
INFO:enrichment.clinicaltrials_client:NO TRIALS: Monobind
INFO:enrichment.clinicaltrials_client:NO TRIALS: Monoceros Biosystems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Monomer Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Montara Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Moon Surgical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Moonwalk Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 1480/2483 (59.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: More Diagnostics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mosaic ImmunoEngineering
INFO:enrichment.clinicaltrials_client:CLINICAL: Motric Bio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Mountain View Pharmaceuticals -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Moximed -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Multiply Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Multispan, Inc.
INFO:enrichment.clinicaltrials_client:CLINICAL: Multitude Therapeutics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MuriGenics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Murrieta Genomics
INFO:enrichment.clinicaltrials_client:Progress: 1490/2483 (60.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Mustang Bio -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: MyBioSource
INFO:enrichment.clinicaltrials_client:NO TRIALS: MyChem
INFO:enrichment.clinicaltrials_client:CLINICAL: MyOme -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Mydecine
INFO:enrichment.clinicaltrials_client:NO TRIALS: Myer Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: Myka Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: MyoGene Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Myocea
INFO:enrichment.clinicaltrials_client:CLINICAL: Myrexis -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 1500/2483 (60.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Myriad Genetics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: N-Power Medicine -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: N1 Life
INFO:enrichment.clinicaltrials_client:NO TRIALS: NAMSA
INFO:enrichment.clinicaltrials_client:NO TRIALS: NAVAN Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: NEOK Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: NGGT -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: NGM Biopharmaceuticals -> 19 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: NKGEN Biotech -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NVIGEN
INFO:enrichment.clinicaltrials_client:Progress: 1510/2483 (60.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: NaNotics
INFO:enrichment.clinicaltrials_client:CLINICAL: Nalo Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nalu Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nammi Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nano Pharmasolutions -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NanoCellect Biomedical
INFO:enrichment.clinicaltrials_client:NO TRIALS: NanoImaging Services
INFO:enrichment.clinicaltrials_client:NO TRIALS: NanoSomiX
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nanome
INFO:enrichment.clinicaltrials_client:CLINICAL: Nanomix -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1520/2483 (61.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nanosyn
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nanotein
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nanotools Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: NantHealth
INFO:enrichment.clinicaltrials_client:NO TRIALS: NantOmics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Narwhal Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Nascent Biotech -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Natera -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nautilus Biotechnology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Navega Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1530/2483 (61.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Navigate BioPharma -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Navire Pharma -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: NeOnc Technologies -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nebula Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeilMed Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Nektar Therapeutics -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeoGenomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Neodyne Biosciences -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neomorph
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neopeutics
INFO:enrichment.clinicaltrials_client:Progress: 1540/2483 (62.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neoteryx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nephroceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Nervonik -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuCyte
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuTherX
INFO:enrichment.clinicaltrials_client:CLINICAL: Neumedicines -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeurOptics
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuraSignal
INFO:enrichment.clinicaltrials_client:CLINICAL: NeuralInk -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Neuralace Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1550/2483 (62.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Neurelis -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuroDigiTech
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuroInDx
INFO:enrichment.clinicaltrials_client:CLINICAL: NeuroLutions -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: NeuroPace -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: NeuroQore -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuroQure
INFO:enrichment.clinicaltrials_client:CLINICAL: NeuroSigma -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: NeuroVigil
INFO:enrichment.clinicaltrials_client:CLINICAL: NeuroVision Imaging -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1560/2483 (62.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neurocarrus
INFO:enrichment.clinicaltrials_client:CLINICAL: Neurocentria -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Neurocrine Biosciences -> 20 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Neurolixis -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Neuron23 -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Neurona Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neuropathix
INFO:enrichment.clinicaltrials_client:CLINICAL: Neuropore Therapies -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Neuros Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neuroservices-Alliance
INFO:enrichment.clinicaltrials_client:Progress: 1570/2483 (63.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Neuspera Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neuvivo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Neuvogen
INFO:enrichment.clinicaltrials_client:CLINICAL: Nevro -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: New Biotic
INFO:enrichment.clinicaltrials_client:NO TRIALS: New England Compounding Center
INFO:enrichment.clinicaltrials_client:CLINICAL: New World Medical -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NewGen Surgical
INFO:enrichment.clinicaltrials_client:NO TRIALS: NewLimit
INFO:enrichment.clinicaltrials_client:CLINICAL: Newave Pharmaceutical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1580/2483 (63.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Newomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Nexcella -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nexilico
INFO:enrichment.clinicaltrials_client:NO TRIALS: NextGen Jane
INFO:enrichment.clinicaltrials_client:NO TRIALS: NextVivo
INFO:enrichment.clinicaltrials_client:CLINICAL: Nexus-Dx -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Niagen Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Nielsen BioSciences -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nihon Kohden -> 12 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nine Square Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1590/2483 (64.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nininger Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nirmidas Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nitrase Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nitto Avecia Pharma Services
INFO:enrichment.clinicaltrials_client:CLINICAL: Nitto BioPharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nittobo America
INFO:enrichment.clinicaltrials_client:CLINICAL: Nivagen -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nkarta Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Noah Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Noctrix Health -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1600/2483 (64.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nodexus
INFO:enrichment.clinicaltrials_client:NO TRIALS: Noetik
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nonagen Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Norac Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: NorthStrive Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Northwest Biotherapeutics -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Norwich Pharma Services -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nosis Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: NovaBay Pharmaceuticals -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Novartis -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 1610/2483 (64.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Novartis Gene Therapies -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Novavax -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Novelna
INFO:enrichment.clinicaltrials_client:NO TRIALS: Novici Biotech
INFO:enrichment.clinicaltrials_client:CLINICAL: Novo Nordisk -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NovoBiotic Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: NovoMedix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Novocuff
INFO:enrichment.clinicaltrials_client:NO TRIALS: Novodiax
INFO:enrichment.clinicaltrials_client:NO TRIALS: Novoron Bioscience
INFO:enrichment.clinicaltrials_client:Progress: 1620/2483 (65.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Novozymes -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Novus International
INFO:enrichment.clinicaltrials_client:CLINICAL: Nowarta Biopharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NoyMed
INFO:enrichment.clinicaltrials_client:NO TRIALS: NuMedii
INFO:enrichment.clinicaltrials_client:CLINICAL: NuVasive -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nucleus Biologics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Numerion Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nura Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Nuravax -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1630/2483 (65.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Nurix Therapeutics -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nusano
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nutcracker Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nutromics
INFO:enrichment.clinicaltrials_client:CLINICAL: Nuvation Bio -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Nuvie Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Nuvig Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Nymox Pharmaceutical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: NysnoBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: O.N. Diagnostics
INFO:enrichment.clinicaltrials_client:Progress: 1640/2483 (66.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: OD-OS -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: ORIC Pharmaceuticals -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: OSNovative Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: OTU Medical -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: OYC Americas
INFO:enrichment.clinicaltrials_client:NO TRIALS: Oblenio Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Ocean Biomedical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Octant Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Octave Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Oculogenex
INFO:enrichment.clinicaltrials_client:Progress: 1650/2483 (66.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ocutrx Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Oddifact
INFO:enrichment.clinicaltrials_client:NO TRIALS: Okami Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Okomera
INFO:enrichment.clinicaltrials_client:NO TRIALS: Olema Oncology
INFO:enrichment.clinicaltrials_client:CLINICAL: Olive Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: OmRx Oncology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ometa Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Omicsveu
INFO:enrichment.clinicaltrials_client:NO TRIALS: OmniAb
INFO:enrichment.clinicaltrials_client:Progress: 1660/2483 (66.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: OmniTier
INFO:enrichment.clinicaltrials_client:NO TRIALS: Omnica
INFO:enrichment.clinicaltrials_client:NO TRIALS: Omniox
INFO:enrichment.clinicaltrials_client:NO TRIALS: Onchilles Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: OncoBox
INFO:enrichment.clinicaltrials_client:NO TRIALS: OncoTracker
INFO:enrichment.clinicaltrials_client:CLINICAL: Oncolytics Biotech -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Oncotelic Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Oncotherapeutics -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Onecrea Medical
INFO:enrichment.clinicaltrials_client:Progress: 1670/2483 (67.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: OnsiteGene
INFO:enrichment.clinicaltrials_client:NO TRIALS: Onyx Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Opal Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: OpenBench
INFO:enrichment.clinicaltrials_client:CLINICAL: Ophirex -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Opna Bio -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Optimum Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Optra Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: OptraScan
INFO:enrichment.clinicaltrials_client:NO TRIALS: Oqory
INFO:enrichment.clinicaltrials_client:Progress: 1680/2483 (67.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: OraSure Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Orbits Oncology
INFO:enrichment.clinicaltrials_client:CLINICAL: Orbus Therapeutics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Orca Bio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Orchid Orthopedic Solutions
INFO:enrichment.clinicaltrials_client:CLINICAL: Orexigen Therapeutics -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Organovo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Origami Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Orlucent -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Orphagen Pharmaceuticals
INFO:enrichment.clinicaltrials_client:Progress: 1690/2483 (68.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Orphina Biotechnology
INFO:enrichment.clinicaltrials_client:CLINICAL: OrsoBio -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: OrthAlign
INFO:enrichment.clinicaltrials_client:CLINICAL: OrthoTrophix -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Oryn Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Osel -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Oska Wellness
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ossur
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ostentus Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ostial Corporation
INFO:enrichment.clinicaltrials_client:Progress: 1700/2483 (68.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Otis Clapp & Son
INFO:enrichment.clinicaltrials_client:CLINICAL: Ouro Medicines -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Outset Medical -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ovation Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Overture Orthopaedics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Owl Drug
INFO:enrichment.clinicaltrials_client:CLINICAL: Oxford BioTherapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: PBS Biotech -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: PCI Pharma Services -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PHASE Scientific Americas
INFO:enrichment.clinicaltrials_client:Progress: 1710/2483 (68.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: PHD Biosciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PLD Pharma Services
INFO:enrichment.clinicaltrials_client:CLINICAL: PPD, Inc. -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PRC Clinical
INFO:enrichment.clinicaltrials_client:NO TRIALS: PSC Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: PTM Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: PUR Biologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: PURE Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pacific BioLabs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pacific BioPharma Logistics
INFO:enrichment.clinicaltrials_client:Progress: 1720/2483 (69.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Pacific Biosciences -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pacific Clinical Research Medical Group
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pacific Immunology
INFO:enrichment.clinicaltrials_client:CLINICAL: Pacific Science -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pacira Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Palisade Bio -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Palm Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pandorum Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Pangea Laboratory -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Papillon Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1730/2483 (69.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Paracrine -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Paragon Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Paramit
INFO:enrichment.clinicaltrials_client:NO TRIALS: Paramune
INFO:enrichment.clinicaltrials_client:NO TRIALS: ParcelBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Particella
INFO:enrichment.clinicaltrials_client:NO TRIALS: Partillion Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Parvus Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PassPort Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Pathnostics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1740/2483 (70.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: PathomIQ
INFO:enrichment.clinicaltrials_client:CLINICAL: Pelage Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Peninsula Research Associates
INFO:enrichment.clinicaltrials_client:CLINICAL: Penumbra -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: PeproMene Bio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Peptide Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: PercAssist
INFO:enrichment.clinicaltrials_client:CLINICAL: Perceive Biotherapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Perceptive Medical -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Perfuse Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1750/2483 (70.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Perrigo -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Persephone Biosciences -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Personalis -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Personalized Stem Cells, Inc. -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Petal Surgical
INFO:enrichment.clinicaltrials_client:CLINICAL: Pfizer -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Phanes Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PharmaLogic
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pharmaceutical Research and Manufacturers of America
INFO:enrichment.clinicaltrials_client:CLINICAL: Pharmatech Associates -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 1760/2483 (70.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Pharmavite -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pharmozyme
INFO:enrichment.clinicaltrials_client:CLINICAL: Phase Scientific -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Pheast Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PhenoVista Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Phenomenex
INFO:enrichment.clinicaltrials_client:NO TRIALS: Phibro Animal Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Philidor Rx Services
INFO:enrichment.clinicaltrials_client:NO TRIALS: Phinomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Phoenix Pharmaceuticals
INFO:enrichment.clinicaltrials_client:Progress: 1770/2483 (71.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: PhorMed
INFO:enrichment.clinicaltrials_client:NO TRIALS: Phylex BioSciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: PiSA USA
INFO:enrichment.clinicaltrials_client:CLINICAL: Piccolo Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pictor
INFO:enrichment.clinicaltrials_client:NO TRIALS: PictorLabs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pimera
INFO:enrichment.clinicaltrials_client:CLINICAL: PinkDx -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Pinnacle Spine -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pinpoint Science
INFO:enrichment.clinicaltrials_client:Progress: 1780/2483 (71.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Plasmidsaurus
INFO:enrichment.clinicaltrials_client:CLINICAL: Pleno -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Plexium
INFO:enrichment.clinicaltrials_client:CLINICAL: Plexxikon -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Pliant Therapeutics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pointcross Life Sciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Polares Medical -> 6 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Polaris Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: PolyPeptide Group
INFO:enrichment.clinicaltrials_client:NO TRIALS: Polybiomics
INFO:enrichment.clinicaltrials_client:Progress: 1790/2483 (72.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Polynoma -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Port Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Portola Pharmaceuticals -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Poseida Therapeutics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Poseidon
INFO:enrichment.clinicaltrials_client:NO TRIALS: Postsurgical Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Potrero Hill Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pragma Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prasco Laboratories
INFO:enrichment.clinicaltrials_client:CLINICAL: Precision BioSciences -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1800/2483 (72.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Precision Motion Health
INFO:enrichment.clinicaltrials_client:CLINICAL: Precision Stability Storage -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: PrecisionMed
INFO:enrichment.clinicaltrials_client:NO TRIALS: Predicine
INFO:enrichment.clinicaltrials_client:NO TRIALS: Predictive Biology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prellis Biologics
INFO:enrichment.clinicaltrials_client:CLINICAL: PreludeDx -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Prescient Imaging -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Presidio Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prestige Consumer Healthcare
INFO:enrichment.clinicaltrials_client:Progress: 1810/2483 (72.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: PrimeVax Immuno-Oncology -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Primmune Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Primrose Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pro-Dex
INFO:enrichment.clinicaltrials_client:CLINICAL: ProLynx -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProPharma Group
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProSci
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProSciento
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProTrials Research
INFO:enrichment.clinicaltrials_client:CLINICAL: Procept BioRobotics -> 12 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1820/2483 (73.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProciseDx
INFO:enrichment.clinicaltrials_client:CLINICAL: Procter & Gamble -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Prodeon Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prodo Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Profluent
INFO:enrichment.clinicaltrials_client:CLINICAL: Profusa -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ProgenaBiome -> 20 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Progenesis
INFO:enrichment.clinicaltrials_client:NO TRIALS: PrognomiQ
INFO:enrichment.clinicaltrials_client:NO TRIALS: Project Outlier
INFO:enrichment.clinicaltrials_client:Progress: 1830/2483 (73.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prolific Machines
INFO:enrichment.clinicaltrials_client:NO TRIALS: Promaxo
INFO:enrichment.clinicaltrials_client:NO TRIALS: Promega
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prometheus Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prominex
INFO:enrichment.clinicaltrials_client:NO TRIALS: Promis Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Prosetta Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Protabit
INFO:enrichment.clinicaltrials_client:CLINICAL: Protagonist Therapeutics -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Protein Fluidics
INFO:enrichment.clinicaltrials_client:Progress: 1840/2483 (74.1%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Protein Sciences -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProteoGenex
INFO:enrichment.clinicaltrials_client:NO TRIALS: ProteoNova
INFO:enrichment.clinicaltrials_client:CLINICAL: Proteon Therapeutics -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Prothena -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Protillion Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Protomer Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Providence Medical Technology -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Provisio Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Proxim Diagnostics
INFO:enrichment.clinicaltrials_client:Progress: 1850/2483 (74.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: PulmoSIM Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Pulmonx -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Pulse Biosciences -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Puma Biotechnology -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Puracyp
INFO:enrichment.clinicaltrials_client:CLINICAL: Purdue Pharma -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: PurePEG
INFO:enrichment.clinicaltrials_client:CLINICAL: PyrAmes -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Pyramid Pharma Services
INFO:enrichment.clinicaltrials_client:NO TRIALS: Q'Apel Medical
INFO:enrichment.clinicaltrials_client:Progress: 1860/2483 (74.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: QA-Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: QED Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: QED Therapeutics -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: QLSF Biotherapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: QT Imaging
INFO:enrichment.clinicaltrials_client:CLINICAL: QT Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: QView Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qardio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qinotto
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qoolabs
INFO:enrichment.clinicaltrials_client:Progress: 1870/2483 (75.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Qpex Biopharma -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Quadriga BioSciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qualer
INFO:enrichment.clinicaltrials_client:CLINICAL: Qualigen Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qualio
INFO:enrichment.clinicaltrials_client:NO TRIALS: QuanDx
INFO:enrichment.clinicaltrials_client:CLINICAL: Quanta Therapeutics -> 3 trials, Clinical Stage
ERROR:enrichment.clinicaltrials_client:Failed to search trials for QuantiScientifics, Inc.: ('Connection aborted.', RemoteDisconnected('Remote end closed connection without response'))
INFO:enrichment.clinicaltrials_client:NO TRIALS: QuantiScientifics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Quantimetrix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Quantumcyte
INFO:enrichment.clinicaltrials_client:Progress: 1880/2483 (75.7%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Quark Pharmaceuticals -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Quartzy
INFO:enrichment.clinicaltrials_client:NO TRIALS: Quick Biology
INFO:enrichment.clinicaltrials_client:NO TRIALS: QuidelOrtho
INFO:enrichment.clinicaltrials_client:CLINICAL: Quince Therapeutics -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Quintara Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Quintara Discovery
INFO:enrichment.clinicaltrials_client:CLINICAL: Quivive Pharma -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qureator
INFO:enrichment.clinicaltrials_client:NO TRIALS: Qvin
INFO:enrichment.clinicaltrials_client:Progress: 1890/2483 (76.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: R2M Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: R3 Vascular -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: RAPT Therapeutics -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: REMD Biotherapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: REVA Medical -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: REVOLUTION Medicines -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ROSE Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: RSIP Vision
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rad AI
INFO:enrichment.clinicaltrials_client:NO TRIALS: Radiance Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1900/2483 (76.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Radionetics Oncology -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: RadiusXR
INFO:enrichment.clinicaltrials_client:CLINICAL: Rain Oncology -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Rakuten Medical -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rampart Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Rampart Health -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Rancho BioSciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Range Biotechnologies -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Rani Therapeutics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: RapidAI
INFO:enrichment.clinicaltrials_client:Progress: 1910/2483 (76.9%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Ray Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: RaySearch Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: RayThera
INFO:enrichment.clinicaltrials_client:CLINICAL: Raydiant Oximetry -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: RayzeBio -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Razor Genomics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ReBlood Rx
INFO:enrichment.clinicaltrials_client:CLINICAL: ReCode Therapeutics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ReCor Medical -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ReValve Solutions
INFO:enrichment.clinicaltrials_client:Progress: 1920/2483 (77.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ReacX Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: RealSeq Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Reata Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Recludix Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: Recognify Life Sciences -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Recombinetics
INFO:enrichment.clinicaltrials_client:NO TRIALS: ReechPharma
INFO:enrichment.clinicaltrials_client:CLINICAL: RefleXion Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Reflow Medical -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: RegCell
INFO:enrichment.clinicaltrials_client:Progress: 1930/2483 (77.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Regel Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Regencor
INFO:enrichment.clinicaltrials_client:CLINICAL: Regeneration Biomedical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Regenerative Patch Technologies -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Regeneron Pharmaceuticals -> 12 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Regulus Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rejuvenate Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Rejuvenation Technologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Reliant Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Relief Cardiovascular
INFO:enrichment.clinicaltrials_client:Progress: 1940/2483 (78.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Renasant Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Renata Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Renova Therapeutics -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Renovaro BioSciences
INFO:enrichment.clinicaltrials_client:CLINICAL: RenovoRx -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Replay
INFO:enrichment.clinicaltrials_client:CLINICAL: Replicate Bioscience -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Repros Therapeutics -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Res Nova Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: ResMed -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1950/2483 (78.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: ResVerlogiX -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ResVita Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: ResearchDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Reservoir Neuroscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Resilience -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Resolute Science -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Resolution Biomedical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Resonetics
INFO:enrichment.clinicaltrials_client:CLINICAL: Respira Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Restem -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 1960/2483 (78.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: RetiNova Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Retro Biosciences -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Retrogen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Retrophin Inc
INFO:enrichment.clinicaltrials_client:NO TRIALS: Retrotope
INFO:enrichment.clinicaltrials_client:NO TRIALS: RevMAB
INFO:enrichment.clinicaltrials_client:NO TRIALS: Revagenix
INFO:enrichment.clinicaltrials_client:CLINICAL: Revel Pharmaceuticals -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Revelation Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ReviR Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1970/2483 (79.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Reviva Pharmaceuticals -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rezo Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Rezolute -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rhausler
INFO:enrichment.clinicaltrials_client:NO TRIALS: RheoSense
INFO:enrichment.clinicaltrials_client:CLINICAL: Riboscience -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Richard Sackler
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ridge Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Rigel Pharmaceuticals -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rila Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 1980/2483 (79.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rio Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Riptide Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Riva Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Roche -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rockley Photonics
INFO:enrichment.clinicaltrials_client:CLINICAL: Rondo Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: RotaChrom Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Route 92 Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rowell Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Royalty Pharma
INFO:enrichment.clinicaltrials_client:Progress: 1990/2483 (80.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rubedo Life Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rubicon Biotechnology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Rune Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: RxSight -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: RyboDyn
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ryght
INFO:enrichment.clinicaltrials_client:NO TRIALS: S2 Genomics
INFO:enrichment.clinicaltrials_client:CLINICAL: SCILEX -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SI-BONE -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SIGA Technologies -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 2000/2483 (80.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: SK Pharmteco
INFO:enrichment.clinicaltrials_client:CLINICAL: SMSbiotech -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: SOHM
INFO:enrichment.clinicaltrials_client:NO TRIALS: SOLVD Health
INFO:enrichment.clinicaltrials_client:CLINICAL: SRI International -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: STA Pharmaceutical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: STAAR Surgical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SUGEN -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Saama Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Saccharo
INFO:enrichment.clinicaltrials_client:Progress: 2010/2483 (81.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sage-N Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: SageMedic
INFO:enrichment.clinicaltrials_client:CLINICAL: Sagimet Biosciences -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sagittarius Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sakura Finetek
INFO:enrichment.clinicaltrials_client:NO TRIALS: Salix Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Samay
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sampling Human
INFO:enrichment.clinicaltrials_client:CLINICAL: SanBio Co Ltd -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: SanDiegOmics
INFO:enrichment.clinicaltrials_client:Progress: 2020/2483 (81.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Sangamo Therapeutics -> 18 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Sanguine Biosciences -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sanovas
INFO:enrichment.clinicaltrials_client:NO TRIALS: Santa Ana Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Santen -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sapient Bioanalytics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sapu BioScience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sardona Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Sarepta Therapeutics -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sayenza Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 2030/2483 (81.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Scale Biosciences -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Scantibodies Laboratory
INFO:enrichment.clinicaltrials_client:CLINICAL: Schrodinger -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: SciGene
INFO:enrichment.clinicaltrials_client:NO TRIALS: SciGenom
INFO:enrichment.clinicaltrials_client:NO TRIALS: SciQuus
INFO:enrichment.clinicaltrials_client:NO TRIALS: ScienCell Research Laboratories
INFO:enrichment.clinicaltrials_client:CLINICAL: Scioderm -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Scribe Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Scripps Laboratories -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 2040/2483 (82.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Seagen -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Seascape Clinical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Seegene
INFO:enrichment.clinicaltrials_client:CLINICAL: Seer -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Segmed
INFO:enrichment.clinicaltrials_client:CLINICAL: Sekisui Diagnostics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Selonterra
INFO:enrichment.clinicaltrials_client:NO TRIALS: Selva Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Semler Scientific -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Senhwa Biosciences -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2050/2483 (82.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Senju Pharmaceutical -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Sensydia -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Senti Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sentia Medical Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sentieon
INFO:enrichment.clinicaltrials_client:CLINICAL: Sention Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Sentynl Therapeutics -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Seonix Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sepragen
INFO:enrichment.clinicaltrials_client:CLINICAL: Septerna -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2060/2483 (83.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: SeqOnce Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sequilite Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Seragon Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Seranova Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Serpex Medical -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: SetPoint Medical -> 8 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Shalby Advanced Technologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Shape Memory Medical -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Shasqi -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Sheffield Pharmaceuticals -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 2070/2483 (83.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Shenandoah Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Shennon Biotechnologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Shockwave Medical -> 12 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Shoreline Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sidewinder Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Siegfried
INFO:enrichment.clinicaltrials_client:CLINICAL: Sight Sciences -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: SigmaGraft
INFO:enrichment.clinicaltrials_client:NO TRIALS: Signios Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sigyn Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 2080/2483 (83.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Silver Bullet Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Silver Creek Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Silver Lake Research -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: SimpleTrials
INFO:enrichment.clinicaltrials_client:NO TRIALS: Simplify Genomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Simpson Interventions -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Single Cell Technology -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Single Pass -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Singular Genomics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sinopia Biosciences
INFO:enrichment.clinicaltrials_client:Progress: 2090/2483 (84.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Siolta Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sira Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Siren Biotechnology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sirenas
INFO:enrichment.clinicaltrials_client:CLINICAL: Sirius Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Skye Biologics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Skye Bioscience -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Slam BioTherapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Slingshot Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Smith Drug Company
INFO:enrichment.clinicaltrials_client:Progress: 2100/2483 (84.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Solaris Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Solaris Medical Technology
INFO:enrichment.clinicaltrials_client:CLINICAL: Soleno Therapeutics -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Somagenics
INFO:enrichment.clinicaltrials_client:CLINICAL: Sommetrics -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SonALAsense -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SonoMotion -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: SonoThera
INFO:enrichment.clinicaltrials_client:CLINICAL: Sonoma Biotherapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Sonorous -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:Progress: 2110/2483 (85.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sony Biotechnology
INFO:enrichment.clinicaltrials_client:CLINICAL: Sorrento Therapeutics -> 20 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sotera Digital Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sovato
INFO:enrichment.clinicaltrials_client:CLINICAL: Spark Therapeutics -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Spartan Micro
INFO:enrichment.clinicaltrials_client:NO TRIALS: Spatial Genomics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Speclipse
INFO:enrichment.clinicaltrials_client:CLINICAL: Spectrum Pharmaceuticals -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Speech Buddies
INFO:enrichment.clinicaltrials_client:Progress: 2120/2483 (85.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Speid & Associates
INFO:enrichment.clinicaltrials_client:CLINICAL: Spinal Elements -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SpineX -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Spinogenix -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Spirair -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Spiral Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Splash Pharmaceuticals -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Spotlight Innovation
INFO:enrichment.clinicaltrials_client:CLINICAL: Spruce Biosciences -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: SpyGlass Pharma -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 2130/2483 (85.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Square-1 Engineering
INFO:enrichment.clinicaltrials_client:NO TRIALS: Stamm Biotech
INFO:enrichment.clinicaltrials_client:NO TRIALS: Standard BioTools
INFO:enrichment.clinicaltrials_client:NO TRIALS: Standard Drug Company (Meridian, Mississippi)
INFO:enrichment.clinicaltrials_client:CLINICAL: Star Therapeutics -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Starlight Cardiovascular -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Stason Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Stately Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Stellartech Research
INFO:enrichment.clinicaltrials_client:NO TRIALS: StemCardia
INFO:enrichment.clinicaltrials_client:Progress: 2140/2483 (86.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: StemCyte -> 5 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Stemedica Cell Technologies -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Steris Applied Sterilization Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sterogene Bioseparations
INFO:enrichment.clinicaltrials_client:CLINICAL: Stiefel Laboratories -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Strategikon Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: Strateos
INFO:enrichment.clinicaltrials_client:NO TRIALS: StrokeDx
INFO:enrichment.clinicaltrials_client:CLINICAL: Stroma Medical -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Structure Therapeutics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2150/2483 (86.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Stryker -> 9 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Studylog
INFO:enrichment.clinicaltrials_client:NO TRIALS: Subsense
INFO:enrichment.clinicaltrials_client:CLINICAL: Subtle Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Summit Therapeutics -> 7 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Summit Toxicology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Sun Valley Research Center
INFO:enrichment.clinicaltrials_client:NO TRIALS: Suneris
INFO:enrichment.clinicaltrials_client:CLINICAL: Sunovion -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Supercede Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 2160/2483 (87.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Superfluid Dx
INFO:enrichment.clinicaltrials_client:NO TRIALS: Superior BioDiagnostics
INFO:enrichment.clinicaltrials_client:CLINICAL: Supira Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Surf Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Surface Ophthalmics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Surge -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Surrozen
INFO:enrichment.clinicaltrials_client:CLINICAL: Sutra Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Sutro Biopharma -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Suture Ease
INFO:enrichment.clinicaltrials_client:Progress: 2170/2483 (87.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Swaza
INFO:enrichment.clinicaltrials_client:CLINICAL: Swing Therapeutics -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Switch Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Sydnexis -> 1 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synageva
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synchronicity Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: Synedgen -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synfini
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synlico
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synova Life Sciences
INFO:enrichment.clinicaltrials_client:Progress: 2180/2483 (87.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synthasome
INFO:enrichment.clinicaltrials_client:NO TRIALS: SyntheX
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synthego
INFO:enrichment.clinicaltrials_client:CLINICAL: Synthekine -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synthetic Design Lab
INFO:enrichment.clinicaltrials_client:NO TRIALS: Synvivia
INFO:enrichment.clinicaltrials_client:NO TRIALS: System Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: T&L Biotechnology -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: T-Cure Bioscience -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: TAE Life Sciences -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 2190/2483 (88.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: TE Connectivity
INFO:enrichment.clinicaltrials_client:NO TRIALS: TEGA Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: THINK Surgical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: TORL BioTherapeutics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: TRIO Pharmaceuticals -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: TRexBio
INFO:enrichment.clinicaltrials_client:CLINICAL: TTI Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tactogen
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tahoe Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Takara Bio USA
INFO:enrichment.clinicaltrials_client:Progress: 2200/2483 (88.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Tallac Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Talphera -> 18 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tandem Diabetes -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tanvex BioPharma -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Taran Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Targazyme -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Target Discovery -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tarsus Pharmaceuticals -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tasman Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Teal Health -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2210/2483 (89.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: TechImmune
INFO:enrichment.clinicaltrials_client:NO TRIALS: Teco Diagnostics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tegmine Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Teikoku Pharma -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Teknova
INFO:enrichment.clinicaltrials_client:NO TRIALS: Telesair
INFO:enrichment.clinicaltrials_client:NO TRIALS: Telesis Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Telios Pharma -> 11 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Telix Pharmaceuticals -> 16 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Telo Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 2220/2483 (89.4%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Tempero Bio -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tempest Therapeutics -> 3 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tempo Bioscience
INFO:enrichment.clinicaltrials_client:CLINICAL: Tempo Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tenaya Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tenex Health -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Tenon Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tentarix Biotherapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tenvie Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Teon Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2230/2483 (89.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: TeraPore Technologies
INFO:enrichment.clinicaltrials_client:CLINICAL: Terns Pharmaceuticals -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Terray Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Terremoto Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: TeselaGen Biotechnology
INFO:enrichment.clinicaltrials_client:CLINICAL: TesoRx -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tetrous
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tetsuwan Scientific
INFO:enrichment.clinicaltrials_client:NO TRIALS: The MT Group
INFO:enrichment.clinicaltrials_client:NO TRIALS: TheraDep Technologies
INFO:enrichment.clinicaltrials_client:Progress: 2240/2483 (90.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: TheraNova -> 13 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Theracyte
INFO:enrichment.clinicaltrials_client:NO TRIALS: Theragene Pharmaceuticals
INFO:enrichment.clinicaltrials_client:NO TRIALS: Theragent
INFO:enrichment.clinicaltrials_client:CLINICAL: Therapeutic Solutions International -> 3 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Therapeutics Inc. -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Theravance Biopharma -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Therini Bio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Thermo Fisher -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Thermopeutix
INFO:enrichment.clinicaltrials_client:Progress: 2250/2483 (90.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Therna Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Third Wave Analytics
INFO:enrichment.clinicaltrials_client:CLINICAL: Thomas Advanced Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Thrive Informatix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tidewave Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tierra Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Timberlyne Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Ting Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tioga Cardiovascular -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tioga Research -> 4 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:Progress: 2260/2483 (91.0%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: TippingPoint Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Tizona Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: TopAlliance Biosciences -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Topos Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: Toragen -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Toro Neurovascular -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: Tosk -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Totus Medicines -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Tr1X -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trace Neuroscience
INFO:enrichment.clinicaltrials_client:Progress: 2270/2483 (91.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tradewind Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tranquis Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Transcripta Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Translucence Biosystems
INFO:enrichment.clinicaltrials_client:CLINICAL: Transposon Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Travere Therapeutics -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Treeline Biosciences -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Trefoil Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Trellis Bioscience -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trepte Biostorage
INFO:enrichment.clinicaltrials_client:Progress: 2280/2483 (91.8%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trestle Biotherapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Trethera -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trevie Research
INFO:enrichment.clinicaltrials_client:CLINICAL: TriArm Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: TriLink Biotechnologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: TriMed
INFO:enrichment.clinicaltrials_client:NO TRIALS: TriWest Research Associates
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trident Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trilo Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trilobio
INFO:enrichment.clinicaltrials_client:Progress: 2290/2483 (92.2%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Triplebar
INFO:enrichment.clinicaltrials_client:CLINICAL: Trishula Therapeutics -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: True Diagnostics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: TrueBinding -> 7 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: TrueRelief
INFO:enrichment.clinicaltrials_client:NO TRIALS: Trukera Medical
INFO:enrichment.clinicaltrials_client:CLINICAL: Trutino Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Truvian Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Tulavi Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: TumorGen
INFO:enrichment.clinicaltrials_client:Progress: 2300/2483 (92.6%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Turn Biotechnologies -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Turn Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Twist Bioscience
INFO:enrichment.clinicaltrials_client:NO TRIALS: TwoStep Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Tyra Biosciences -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: UTAK Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: Uh-Oh Labs
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ultima Genomics
INFO:enrichment.clinicaltrials_client:CLINICAL: Ultragenyx Pharmaceutical -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Unchained Labs
INFO:enrichment.clinicaltrials_client:Progress: 2310/2483 (93.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Unicycive Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Uniquity Bio
INFO:enrichment.clinicaltrials_client:CLINICAL: United Biologics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: United Pharmaceutical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Universal Brain
INFO:enrichment.clinicaltrials_client:NO TRIALS: Universal Sequencing Technology
INFO:enrichment.clinicaltrials_client:NO TRIALS: Universal Stabilization Technologies (Vitrilife)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Univfy
INFO:enrichment.clinicaltrials_client:NO TRIALS: Unlearn
INFO:enrichment.clinicaltrials_client:NO TRIALS: Unnatural Products
INFO:enrichment.clinicaltrials_client:Progress: 2320/2483 (93.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Until Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: Uptake Medical -> 10 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ur24Technology
INFO:enrichment.clinicaltrials_client:NO TRIALS: UroViu
INFO:enrichment.clinicaltrials_client:NO TRIALS: VIAL Dermatology CRO
INFO:enrichment.clinicaltrials_client:CLINICAL: VIAN Therapeutics -> 2 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: VIVUS -> 19 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: VLP Biotech -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: VM Oncology -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: VST Bio
INFO:enrichment.clinicaltrials_client:Progress: 2330/2483 (93.8%)
INFO:enrichment.clinicaltrials_client:CLINICAL: VahatiCor -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vala Sciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Valar Labs
INFO:enrichment.clinicaltrials_client:CLINICAL: Valencia Technologies -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Validation Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Valitor
INFO:enrichment.clinicaltrials_client:NO TRIALS: Valora Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vantis Vascular
INFO:enrichment.clinicaltrials_client:NO TRIALS: Varda
INFO:enrichment.clinicaltrials_client:CLINICAL: Varian Medical Systems -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2340/2483 (94.2%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Vasa Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: VasoRx
INFO:enrichment.clinicaltrials_client:CLINICAL: VaxCyte -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vaxart -> 8 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vaxiion Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vector Laboratories
INFO:enrichment.clinicaltrials_client:NO TRIALS: VedaBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: Veebot
INFO:enrichment.clinicaltrials_client:NO TRIALS: Veeva Systems
INFO:enrichment.clinicaltrials_client:CLINICAL: Vektor Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2350/2483 (94.6%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Velorum Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Venova Medical -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Venquis Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ventoux Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ventris Medical
INFO:enrichment.clinicaltrials_client:CLINICAL: Ventrix -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Ventyx Biosciences -> 3 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vera Therapeutics -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Veracyte -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Verana Health
INFO:enrichment.clinicaltrials_client:Progress: 2360/2483 (95.0%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Verge Genomics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: VeriSIM Life
INFO:enrichment.clinicaltrials_client:CLINICAL: Verily Life Sciences -> 11 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Verndari
INFO:enrichment.clinicaltrials_client:CLINICAL: Versa Vascular -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: VersaPeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Verseon
INFO:enrichment.clinicaltrials_client:CLINICAL: Vertex -> 17 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vertos Medical -> 6 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vesicor Therapeutics
INFO:enrichment.clinicaltrials_client:Progress: 2370/2483 (95.4%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ViCardia Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: ViQi
INFO:enrichment.clinicaltrials_client:NO TRIALS: Via Nova Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: ViaLase -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Viage Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Viant Medical
INFO:enrichment.clinicaltrials_client:CLINICAL: Vibrant America Clinical Laboratory -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vibrato Medical -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vicinitas Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: VictoGen
INFO:enrichment.clinicaltrials_client:Progress: 2380/2483 (95.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Videra Surgical
INFO:enrichment.clinicaltrials_client:CLINICAL: Viking Therapeutics -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vir Biotechnology -> 13 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vironexis Biotherapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Virtuoso Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Visby Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Viscient Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Viseon
INFO:enrichment.clinicaltrials_client:NO TRIALS: Visgenx
INFO:enrichment.clinicaltrials_client:NO TRIALS: VisiCELL Medical
INFO:enrichment.clinicaltrials_client:Progress: 2390/2483 (96.3%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vista.ai
INFO:enrichment.clinicaltrials_client:CLINICAL: Vistagen Therapeutics -> 11 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: VitalConnect -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vitalex Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Vivace Therapeutics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Vivani Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vivera Pharmaceuticals
INFO:enrichment.clinicaltrials_client:CLINICAL: Vividion Therapeutics -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vivreon Biosciences
INFO:enrichment.clinicaltrials_client:CLINICAL: Viz.ai -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2400/2483 (96.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Voiant Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vonova.io
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vulcan Biologics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Vybion
INFO:enrichment.clinicaltrials_client:NO TRIALS: Wainamics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Wakunaga Pharmaceutical
INFO:enrichment.clinicaltrials_client:CLINICAL: Wallaby Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: West Coast Research -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: Wield Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: WinSanTor -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2410/2483 (97.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: Wincal BioPharm
INFO:enrichment.clinicaltrials_client:NO TRIALS: WuXi Apptec
INFO:enrichment.clinicaltrials_client:NO TRIALS: X-Therma
INFO:enrichment.clinicaltrials_client:NO TRIALS: XCellAssay
INFO:enrichment.clinicaltrials_client:NO TRIALS: XENSE
INFO:enrichment.clinicaltrials_client:CLINICAL: XII Medical -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Xaira Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: Xcell Biosciences
INFO:enrichment.clinicaltrials_client:NO TRIALS: Xcell Science
INFO:enrichment.clinicaltrials_client:NO TRIALS: Xenco Medical
INFO:enrichment.clinicaltrials_client:Progress: 2420/2483 (97.5%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Xencor -> 15 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: XiltriX
INFO:enrichment.clinicaltrials_client:NO TRIALS: Ximedica
INFO:enrichment.clinicaltrials_client:NO TRIALS: Xosomix
INFO:enrichment.clinicaltrials_client:NO TRIALS: Xyphos
INFO:enrichment.clinicaltrials_client:NO TRIALS: Y-Trap
INFO:enrichment.clinicaltrials_client:NO TRIALS: Yatiri Bio
INFO:enrichment.clinicaltrials_client:NO TRIALS: YenZym Antibodies
INFO:enrichment.clinicaltrials_client:CLINICAL: YourChoice Therapeutics -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Yuvan Research
INFO:enrichment.clinicaltrials_client:Progress: 2430/2483 (97.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ZAP Surgical
INFO:enrichment.clinicaltrials_client:CLINICAL: ZKR Orthopedics -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ZMI Pharma
INFO:enrichment.clinicaltrials_client:CLINICAL: ZabBio -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zafrens
INFO:enrichment.clinicaltrials_client:CLINICAL: Zai Lab -> 14 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: ZebraSci
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zeda
INFO:enrichment.clinicaltrials_client:NO TRIALS: ZefSci
INFO:enrichment.clinicaltrials_client:CLINICAL: Zenflow -> 5 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2440/2483 (98.3%)
INFO:enrichment.clinicaltrials_client:CLINICAL: Zenith Epigenetics -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zenobia Fragments
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zenobia Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: Zenshine Pharmaceuticals -> 15 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Zensun Sci & Tech -> 10 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: Zentalis Pharmaceuticals -> 11 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zeon Systems
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zerigo Health
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zeto
INFO:enrichment.clinicaltrials_client:CLINICAL: Zoll -> 14 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:Progress: 2450/2483 (98.7%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: ZoneOne Pharma
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zyagen
INFO:enrichment.clinicaltrials_client:NO TRIALS: ZymagenX
INFO:enrichment.clinicaltrials_client:NO TRIALS: Zymo Research
INFO:enrichment.clinicaltrials_client:CLINICAL: aTyr Pharma -> 9 trials, Public/Late-Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: ashibio -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: atHeart Medical -> 2 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: eLum Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: eMed Technologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: eXoZymes
INFO:enrichment.clinicaltrials_client:Progress: 2460/2483 (99.1%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: enVVeno Medical
INFO:enrichment.clinicaltrials_client:NO TRIALS: f5 Therapeutics
INFO:enrichment.clinicaltrials_client:NO TRIALS: fluidIQ
INFO:enrichment.clinicaltrials_client:NO TRIALS: iBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: iCRAS
INFO:enrichment.clinicaltrials_client:NO TRIALS: iLeukon Therapeutics
INFO:enrichment.clinicaltrials_client:CLINICAL: iNanoBio -> 1 trials, Unknown
INFO:enrichment.clinicaltrials_client:CLINICAL: iQ Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: iRhythm Technologies -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: iSono Health
INFO:enrichment.clinicaltrials_client:Progress: 2470/2483 (99.5%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: iXCells Biotechnologies
INFO:enrichment.clinicaltrials_client:NO TRIALS: insitro
INFO:enrichment.clinicaltrials_client:CLINICAL: iota Biosciences -> 1 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:NO TRIALS: iuvo BioScience
INFO:enrichment.clinicaltrials_client:CLINICAL: jCyte -> 4 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:CLINICAL: joimax -> 2 trials, Unknown
INFO:enrichment.clinicaltrials_client:NO TRIALS: mFluiDx
INFO:enrichment.clinicaltrials_client:NO TRIALS: nRichDX
INFO:enrichment.clinicaltrials_client:NO TRIALS: nanoComposix
INFO:enrichment.clinicaltrials_client:NO TRIALS: neuro42
INFO:enrichment.clinicaltrials_client:Progress: 2480/2483 (99.9%)
INFO:enrichment.clinicaltrials_client:NO TRIALS: resistanceBio
INFO:enrichment.clinicaltrials_client:NO TRIALS: tag.bio
INFO:enrichment.clinicaltrials_client:CLINICAL: xCures -> 6 trials, Clinical Stage
INFO:enrichment.clinicaltrials_client:============================================================
INFO:enrichment.clinicaltrials_client:CLINICAL TRIALS ENRICHMENT COMPLETE
INFO:enrichment.clinicaltrials_client:============================================================
INFO:enrichment.clinicaltrials_client:Total processed: 2483
INFO:enrichment.clinicaltrials_client:Companies with trials: 1556
INFO:enrichment.clinicaltrials_client:Clinical stage identified: 1023
INFO:enrichment.clinicaltrials_client:Errors: 0
INFO:enrichment.clinicaltrials_client:Clinical trials coverage: 43.4%
INFO:__main__:Getting initial classification statistics...
INFO:__main__:
================================================================================
INFO:__main__:EXHAUSTIVE ENRICHMENT FINAL REPORT
INFO:__main__:================================================================================
INFO:__main__:
Execution Time: 7h 35m 3s
INFO:__main__:
--------------------------------------------------------------------------------
INFO:__main__:PROCESSING STATISTICS
INFO:__main__:--------------------------------------------------------------------------------
INFO:__main__:Total companies in database: 2491
INFO:__main__:SEC EDGAR processed: 0
INFO:__main__:  - Filings found: 0
INFO:__main__:  - Public companies identified: 0
INFO:__main__:ClinicalTrials processed: 2483
INFO:__main__:  - Trials found: 1556
INFO:__main__:  - Clinical stage identified: 1023
INFO:__main__:Errors encountered: 0
INFO:__main__:
--------------------------------------------------------------------------------
INFO:__main__:CLASSIFICATION IMPROVEMENT
INFO:__main__:--------------------------------------------------------------------------------
INFO:__main__:
BEFORE ENRICHMENT:
INFO:__main__:  Clinical Stage           :    3 (  0.1%)
INFO:__main__:  Public                   :  423 ( 17.0%)
INFO:__main__:  Public/Late-Stage        :    1 (  0.0%)
INFO:__main__:  Unclassified             : 2064 ( 82.9%)
INFO:__main__:
AFTER ENRICHMENT:
INFO:__main__:  Clinical Stage           :  721 ( 28.9%)
INFO:__main__:  Public                   :  600 ( 24.1%)
INFO:__main__:  Public/Late-Stage        :  306 ( 12.3%)
INFO:__main__:  Unclassified             :  864 ( 34.7%)
INFO:__main__:
IMPROVEMENT:
INFO:__main__:  Companies newly classified: 1200
INFO:__main__:  Unclassified companies reduced by: 1200 (58.1%)
INFO:__main__:  Unclassified percentage reduced from 82.9% to 34.7%
INFO:__main__:
Report saved to: logs/enrichment_report_20251116_124943.txt
INFO:__main__:
================================================================================
INFO:__main__:EXHAUSTIVE ENRICHMENT COMPLETE
INFO:__main__:================================================================================
